BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A 2014;111:787-92. [PMID: 24277828 DOI: 10.1073/pnas.1314688110] [Cited by in Crossref: 351] [Cited by in F6Publishing: 321] [Article Influence: 39.0] [Reference Citation Analysis]
Number Citing Articles
1 Blackwood JC, Cummings DA, Iamsirithaworn S, Rohani P. Using age-stratified incidence data to examine the transmission consequences of pertussis vaccination. Epidemics 2016;16:1-7. [PMID: 27663785 DOI: 10.1016/j.epidem.2016.02.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Hovingh ES, de Maat S, Cloherty APM, Johnson S, Pinelli E, Maas C, Jongerius I. Virulence Associated Gene 8 of Bordetella pertussis Enhances Contact System Activity by Inhibiting the Regulatory Function of Complement Regulator C1 Inhibitor. Front Immunol 2018;9:1172. [PMID: 29915576 DOI: 10.3389/fimmu.2018.01172] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
3 Hill K, Arsic N, Nordstrom S, Griebel PJ. Immune memory induced by intranasal vaccination with a modified-live viral vaccine delivered to colostrum fed neonatal calves. Vaccine 2019;37:7455-62. [DOI: 10.1016/j.vaccine.2019.09.080] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
4 Versteegen P, Valente Pinto M, Barkoff AM, van Gageldonk PGM, van de Kassteele J, van Houten MA, Sanders EAM, de Groot R, Diavatopoulos DA, Bibi S, Luoto R, He Q, Buisman AM, Kelly DF, Mertsola J, Berbers GAM. Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United Kingdom. EBioMedicine 2021;65:103247. [PMID: 33647770 DOI: 10.1016/j.ebiom.2021.103247] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
5 Belcher T, Preston A. Bordetella pertussis evolution in the (functional) genomics era. Pathog Dis 2015;73:ftv064. [PMID: 26297914 DOI: 10.1093/femspd/ftv064] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
6 Najminejad H, Kalantar SM, Mokarram AR, Dabaghian M, Abdollahpour-Alitappeh M, Ebrahimi SM, Tebianian M, Fasihi Ramandi M, Sheikhha MH. Bordetella pertussis antigens encapsulated into N-trimethyl chitosan nanoparticulate systems as a novel intranasal pertussis vaccine. Artif Cells Nanomed Biotechnol 2019;47:2605-11. [PMID: 31240957 DOI: 10.1080/21691401.2019.1629948] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
7 Atkins KE, Lafferty EI, Deeny SR, Davies NG, Robotham JV, Jit M. Use of mathematical modelling to assess the impact of vaccines on antibiotic resistance. Lancet Infect Dis 2018;18:e204-13. [PMID: 29146178 DOI: 10.1016/S1473-3099(17)30478-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 5.6] [Reference Citation Analysis]
8 Solans L, Locht C. The Role of Mucosal Immunity in Pertussis. Front Immunol 2018;9:3068. [PMID: 30692990 DOI: 10.3389/fimmu.2018.03068] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
9 Argondizo-Correia C, Rodrigues AKS, de Brito CA. Neonatal Immunity to Bordetella pertussis Infection and Current Prevention Strategies. J Immunol Res 2019;2019:7134168. [PMID: 30882004 DOI: 10.1155/2019/7134168] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
10 Raeven RH, Brummelman J, Pennings JL, Nijst OE, Kuipers B, Blok LE, Helm K, van Riet E, Jiskoot W, van Els CA, Han WG, Kersten GF, Metz B. Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection. PLoS One 2014;9:e104548. [PMID: 25137043 DOI: 10.1371/journal.pone.0104548] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
11 Seubert A, D'Oro U, Scarselli M, Pizza M. Genetically detoxified pertussis toxin (PT-9K/129G): implications for immunization and vaccines. Expert Rev Vaccines 2014;13:1191-204. [PMID: 25183193 DOI: 10.1586/14760584.2014.942641] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
12 van Twillert I, Bonačić Marinović AA, van Gaans-van den Brink JA, Kuipers B, Berbers GA, van der Maas NA, Verheij TJ, Versteegh FG, Teunis PF, van Els CA. The Use of Innovative Two-Component Cluster Analysis and Serodiagnostic Cut-Off Methods to Estimate Prevalence of Pertussis Reinfections. PLoS One 2016;11:e0148507. [PMID: 26848833 DOI: 10.1371/journal.pone.0148507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Cho BH, Acosta AM, Leidner AJ, Faulkner AE, Zhou F. Tetanus, diphtheria and acellular pertussis (Tdap) vaccine for prevention of pertussis among adults aged 19 years and older in the United States: A cost-effectiveness analysis. Prev Med 2020;134:106066. [PMID: 32199910 DOI: 10.1016/j.ypmed.2020.106066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Petousis-Harris H, Jiang Y, Yu L, Watson D, Walls T, Turner N, Howe AS, Griffin JB. A Retrospective Cohort Study of Safety Outcomes in New Zealand Infants Exposed to Tdap Vaccine in Utero. Vaccines (Basel) 2019;7:E147. [PMID: 31614582 DOI: 10.3390/vaccines7040147] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
15 Domenech de Cellès M, Magpantay FMG, King AA, Rohani P. The impact of past vaccination coverage and immunity on pertussis resurgence. Sci Transl Med 2018;10:eaaj1748. [PMID: 29593103 DOI: 10.1126/scitranslmed.aaj1748] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 14.3] [Reference Citation Analysis]
16 Kusinitz M, Braunstein E, Wilson CA. Advancing Public Health Using Regulatory Science to Enhance Development and Regulation of Medical Products: Food and Drug Administration Research at the Center for Biologics Evaluation and Research. Front Med (Lausanne) 2017;4:71. [PMID: 28660187 DOI: 10.3389/fmed.2017.00071] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
17 Misiak A, Leuzzi R, Allen AC, Galletti B, Baudner BC, D'Oro U, O'Hagan DT, Pizza M, Seubert A, Mills KHG. Addition of a TLR7 agonist to an acellular pertussis vaccine enhances Th1 and Th17 responses and protective immunity in a mouse model. Vaccine 2017;35:5256-63. [PMID: 28823618 DOI: 10.1016/j.vaccine.2017.08.009] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
18 Debrie AS, Coutte L, Raze D, Mooi F, Alexander F, Gorringe A, Mielcarek N, Locht C. Construction and evaluation of Bordetella pertussis live attenuated vaccine strain BPZE1 producing Fim3. Vaccine 2018;36:1345-52. [PMID: 29433898 DOI: 10.1016/j.vaccine.2018.02.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
19 Gestal MC, Howard LK, Dewan KK, Harvill ET. Bbvac: A Live Vaccine Candidate That Provides Long-Lasting Anamnestic and Th17-Mediated Immunity against the Three Classical Bordetella spp. mSphere 2022;7:e0089221. [PMID: 35196124 DOI: 10.1128/msphere.00892-21] [Reference Citation Analysis]
20 Kurehong C, Kanchanawarin C, Powthongchin B, Prangkio P, Katzenmeier G, Angsuthanasombat C. Functional Contributions of Positive Charges in the Pore-Lining Helix 3 of the Bordetella pertussis CyaA-Hemolysin to Hemolytic Activity and Ion-Channel Opening. Toxins (Basel) 2017;9:E109. [PMID: 28300777 DOI: 10.3390/toxins9030109] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
21 Han WG, Hodemaekers HM, Nagarajah B, Poelen MM, Helm K, Janssen R, van Els CA. Association of Vitamin D Receptor Polymorphism with Susceptibility to Symptomatic Pertussis. PLoS One 2016;11:e0149576. [PMID: 26894582 DOI: 10.1371/journal.pone.0149576] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
22 Solans L, Debrie AS, Borkner L, Aguiló N, Thiriard A, Coutte L, Uranga S, Trottein F, Martín C, Mills KHG, Locht C. IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine. Mucosal Immunol 2018;11:1753-62. [PMID: 30115992 DOI: 10.1038/s41385-018-0073-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 7.5] [Reference Citation Analysis]
23 Langsam D, Kahana D, Shmueli E, Yamin D. Cost-Effectiveness of Pertussis Vaccination Schedule in Israel. Vaccines (Basel) 2021;9:590. [PMID: 34199574 DOI: 10.3390/vaccines9060590] [Reference Citation Analysis]
24 Zurita-Gutiérrez YH, Lion S. Spatial structure, host heterogeneity and parasite virulence: implications for vaccine-driven evolution. Ecol Lett 2015;18:779-89. [PMID: 26052783 DOI: 10.1111/ele.12455] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
25 Naninck T, Contreras V, Coutte L, Langlois S, Hébert-Ribon A, Pelletier M, Reveneau N, Locht C, Chapon C, Le Grand R. Intranasal inoculation with Bordetella pertussis confers protection without inducing classical whooping cough in baboons. Curr Res Microb Sci 2021;2:100072. [PMID: 34841362 DOI: 10.1016/j.crmicr.2021.100072] [Reference Citation Analysis]
26 Geurtsen J, Fae KC, van den Dobbelsteen GP. Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis. Expert Rev Vaccines 2014;13:1229-40. [PMID: 25081731 DOI: 10.1586/14760584.2014.944901] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
27 Bolotin S, Johnson C, Quach S, Ambrose A, DeCoutere S, Deeks SL, Drews S, Faheem A, Green K, Halperin SA, Hoang L, Jamieson F, Kollmann T, Marchand-Austin A, McCormack D, McGeer A, Murti M, Bba AO, Rebbapragada A, Vanderkooi OG, Wang J, Warshawsky B, Crowcroft NS; Canadian Immunization Research Network Provincial Collaborative Network. Case-control study of household contacts to examine immunological protection from Bordetella pertussis transmission - study protocol. CMAJ Open 2017;5:E872-7. [PMID: 29269437 DOI: 10.9778/cmajo.20170072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
28 Wilk MM, Borkner L, Misiak A, Curham L, Allen AC, Mills KHG. Immunization with whole cell but not acellular pertussis vaccines primes CD4 TRM cells that sustain protective immunity against nasal colonization with Bordetella pertussis. Emerg Microbes Infect 2019;8:169-85. [PMID: 30866771 DOI: 10.1080/22221751.2018.1564630] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 11.7] [Reference Citation Analysis]
29 Cherry JD. Adult pertussis in the pre- and post-vaccine eras: lifelong vaccine-induced immunity? Expert Review of Vaccines 2014;13:1073-80. [DOI: 10.1586/14760584.2014.935765] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
30 Riolo MA, Rohani P. Combating pertussis resurgence: One booster vaccination schedule does not fit all. Proc Natl Acad Sci U S A 2015;112:E472-7. [PMID: 25605878 DOI: 10.1073/pnas.1415573112] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
31 Shi W, Kou Y, Jiang H, Gao F, Kong W, Su W, Xu F, Jiang C. Novel intranasal pertussis vaccine based on bacterium-like particles as a mucosal adjuvant. Immunol Lett 2018;198:26-32. [PMID: 29601940 DOI: 10.1016/j.imlet.2018.03.012] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
32 Majzoobi MM, Macvandi MR, Basir HG, Sanaei Z, Mazaheri S, Afza M, Arabestani MR. The role of Bordetella pertussis in the development of multiple sclerosis. BMC Neurol 2022;22:70. [PMID: 35232387 DOI: 10.1186/s12883-022-02606-4] [Reference Citation Analysis]
33 Bontempi I, Vicco MH, Bayry J. Chronic Chagas disease: can prophylaxis and therapeutic vaccines crack this ‘hard nut’? Immunotherapy 2016;8:99-101. [DOI: 10.2217/imt.15.115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
34 Fedele G, Carollo M, Palazzo R, Stefanelli P, Pandolfi E, Gesualdo F, Tozzi AE, Carsetti R, Villani A, Nicolai A, Midulla F, Ausiello CM; Pertussis Study Group. Parents as source of pertussis transmission in hospitalized young infants. Infection 2017;45:171-8. [PMID: 27614887 DOI: 10.1007/s15010-016-0943-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
35 Lumbreras Areta M, Eberhardt CS, Siegrist CA, Martinez de Tejada B. Antenatal vaccination to decrease pertussis in infants: safety, effectiveness, timing, and implementation. J Matern Fetal Neonatal Med 2019;32:1541-6. [PMID: 29199493 DOI: 10.1080/14767058.2017.1406475] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
36 Domenech de Cellès M, King AA, Rohani P. Commentary: resolving pertussis resurgence and vaccine immunity using mathematical transmission models. Hum Vaccin Immunother 2019;15:683-6. [PMID: 30457424 DOI: 10.1080/21645515.2018.1549432] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
37 Tian Y, da Silva Antunes R, Sidney J, Lindestam Arlehamn CS, Grifoni A, Dhanda SK, Paul S, Peters B, Weiskopf D, Sette A. A Review on T Cell Epitopes Identified Using Prediction and Cell-Mediated Immune Models for Mycobacterium tuberculosis and Bordetella pertussis. Front Immunol 2018;9:2778. [PMID: 30555469 DOI: 10.3389/fimmu.2018.02778] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
38 Melvin JA, Scheller EV, Miller JF, Cotter PA. Bordetella pertussis pathogenesis: current and future challenges. Nat Rev Microbiol 2014;12:274-88. [PMID: 24608338 DOI: 10.1038/nrmicro3235] [Cited by in Crossref: 195] [Cited by in F6Publishing: 162] [Article Influence: 24.4] [Reference Citation Analysis]
39 Wu V, Smith AA, You H, Nguyen TA, Ferguson R, Taylor M, Park JE, Llontop P, Youngman KR, Abramson T. Plasmacytoid dendritic cell-derived IFNα modulates Th17 differentiation during early Bordetella pertussis infection in mice. Mucosal Immunol 2016;9:777-86. [DOI: 10.1038/mi.2015.101] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
40 Gorringe AR, Vaughan TE. Bordetella pertussis fimbriae (Fim): relevance for vaccines. Expert Rev Vaccines 2014;13:1205-14. [PMID: 25102891 DOI: 10.1586/14760584.2014.930667] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
41 Locht C. The Path to New Pediatric Vaccines against Pertussis. Vaccines (Basel) 2021;9:228. [PMID: 33807962 DOI: 10.3390/vaccines9030228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Rubin K, Glazer S. The Potential Role of Subclinical Bordetella pertussis Infection in Epilepsy. Front Cell Infect Microbiol 2019;9:302. [PMID: 31555605 DOI: 10.3389/fcimb.2019.00302] [Reference Citation Analysis]
43 Kennedy DA, Read AF. Why does drug resistance readily evolve but vaccine resistance does not? Proc Biol Sci 2017;284:20162562. [PMID: 28356449 DOI: 10.1098/rspb.2016.2562] [Cited by in Crossref: 63] [Cited by in F6Publishing: 45] [Article Influence: 15.8] [Reference Citation Analysis]
44 Lemaitre J, Naninck T, Delache B, Creppy J, Huber P, Holzapfel M, Bouillier C, Contreras V, Martinon F, Kahlaoui N, Pascal Q, Tricot S, Ducancel F, Vecellio L, Le Grand R, Maisonnasse P. Non-human primate models of human respiratory infections. Mol Immunol 2021;135:147-64. [PMID: 33895579 DOI: 10.1016/j.molimm.2021.04.010] [Reference Citation Analysis]
45 Sartoretti J, Eberhardt CS. The Potential Role of Nonhuman Primate Models to Better Comprehend Early Life Immunity and Maternal Antibody Transfer. Vaccines (Basel) 2021;9:306. [PMID: 33804886 DOI: 10.3390/vaccines9040306] [Reference Citation Analysis]
46 Rivera I, Linz B, Harvill ET. Evolution and Conservation of Bordetella Intracellular Survival in Eukaryotic Host Cells. Front Microbiol 2020;11:557819. [PMID: 33178148 DOI: 10.3389/fmicb.2020.557819] [Reference Citation Analysis]
47 Fitzpatrick MC, Wenzel NS, Scarpino SV, Althouse BM, Atkins KE, Galvani AP, Townsend JP. Cost-effectiveness of next-generation vaccines: The case of pertussis. Vaccine 2016;34:3405-11. [PMID: 27087151 DOI: 10.1016/j.vaccine.2016.04.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
48 Petráčková D, Farman MR, Amman F, Linhartová I, Dienstbier A, Kumar D, Držmíšek J, Hofacker I, Rodriguez ME, Večerek B. Transcriptional profiling of human macrophages during infection with Bordetella pertussis. RNA Biol 2020;17:731-42. [PMID: 32070192 DOI: 10.1080/15476286.2020.1727694] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
49 Raeven RH, Brummelman J, van der Maas L, Tilstra W, Pennings JL, Han WG, van Els CA, van Riet E, Kersten GF, Metz B. Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune Cells. PLoS One 2016;11:e0164027. [PMID: 27711188 DOI: 10.1371/journal.pone.0164027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
50 Kahan DM. Vaccine Risk Perceptions and Ad Hoc Risk Communication: An Empirical Assessment. SSRN Journal. [DOI: 10.2139/ssrn.2386034] [Cited by in Crossref: 20] [Reference Citation Analysis]
51 Zuo W, Li J, Jiang W, Zhang M, Ma Y, Gu Q, Wang X, Cai L, Shi L, Sun M. Dose-Sparing Intradermal DTaP-sIPV Immunization With a Hollow Microneedle Leads to Superior Immune Responses. Front Microbiol 2021;12:757375. [PMID: 34759909 DOI: 10.3389/fmicb.2021.757375] [Reference Citation Analysis]
52 van Twillert I, Han WG, van Els CA. Waning and aging of cellular immunity to Bordetella pertussis. Pathog Dis 2015;73:ftv071. [PMID: 26371178 DOI: 10.1093/femspd/ftv071] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
53 Seppälä E, Bråthen Kristoffersen A, Bøås H, Frimann Vestrheim D, Greve-isdahl M, Freiesleben De Blasio B, Steens A. Pertussis epidemiology including direct and indirect effects of the childhood pertussis booster vaccinations, Norway, 1998–2019. Vaccine 2022. [DOI: 10.1016/j.vaccine.2022.04.038] [Reference Citation Analysis]
54 Lapidot R, Gill CJ. The Pertussis resurgence: putting together the pieces of the puzzle. Trop Dis Travel Med Vaccines 2016;2:26. [PMID: 28883970 DOI: 10.1186/s40794-016-0043-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
55 Cherry JD. The 112-Year Odyssey of Pertussis and Pertussis Vaccines-Mistakes Made and Implications for the Future. J Pediatric Infect Dis Soc 2019;8:334-41. [PMID: 30793754 DOI: 10.1093/jpids/piz005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
56 Edwards KM. Unraveling the challenges of pertussis. Proc Natl Acad Sci U S A 2014;111:575-6. [PMID: 24381159 DOI: 10.1073/pnas.1321360111] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
57 Rubin K, Glazer S. The potential role of subclinical Bordetella Pertussis colonization in the etiology of multiple sclerosis. Immunobiology 2016;221:512-5. [DOI: 10.1016/j.imbio.2015.12.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
58 van Beek LF, de Gouw D, Eleveld MJ, Bootsma HJ, de Jonge MI, Mooi FR, Zomer A, Diavatopoulos DA. Adaptation of Bordetella pertussis to the Respiratory Tract. J Infect Dis 2018;217:1987-96. [PMID: 29528444 DOI: 10.1093/infdis/jiy125] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
59 Cabrera G, Marcipar I. Vaccines and the regulatory arm of the immune system. An overview from the Trypanosoma cruzi infection model. Vaccine 2019;37:3628-37. [PMID: 31155420 DOI: 10.1016/j.vaccine.2019.05.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
60 Magpantay FM, Rohani P. Dynamics of Pertussis Transmission in the United States. Am J Epidemiol 2015;181:921-31. [PMID: 26022662 DOI: 10.1093/aje/kwv024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
61 Sebo P, Osicka R, Masin J. Adenylate cyclase toxin-hemolysin relevance for pertussis vaccines. Expert Rev Vaccines 2014;13:1215-27. [PMID: 25090574 DOI: 10.1586/14760584.2014.944900] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 4.4] [Reference Citation Analysis]
62 Kapil P, Merkel TJ. Pertussis vaccines and protective immunity. Curr Opin Immunol 2019;59:72-8. [PMID: 31078081 DOI: 10.1016/j.coi.2019.03.006] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 10.3] [Reference Citation Analysis]
63 Tan T, Dalby T, Forsyth K, Halperin SA, Heininger U, Hozbor D, Plotkin S, Ulloa-Gutierrez R, Wirsing von König CH. Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013. Pediatr Infect Dis J 2015;34:e222-32. [PMID: 26376316 DOI: 10.1097/INF.0000000000000795] [Cited by in Crossref: 140] [Cited by in F6Publishing: 66] [Article Influence: 23.3] [Reference Citation Analysis]
64 Burdin N, Handy LK, Plotkin SA. What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines. Cold Spring Harb Perspect Biol 2017;9:a029454. [PMID: 28289064 DOI: 10.1101/cshperspect.a029454] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 8.2] [Reference Citation Analysis]
65 Sealey KL, Belcher T, Preston A. Bordetella pertussis epidemiology and evolution in the light of pertussis resurgence. Infect Genet Evol 2016;40:136-43. [PMID: 26932577 DOI: 10.1016/j.meegid.2016.02.032] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 7.2] [Reference Citation Analysis]
66 Coutte L, Locht C. Investigating pertussis toxin and its impact on vaccination. Future Microbiol 2015;10:241-54. [PMID: 25689536 DOI: 10.2217/fmb.14.123] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
67 Fiasca F, Gabutti G, Mattei A. Trends in Hospital Admissions for Pertussis Infection: A Nationwide Retrospective Observational Study in Italy, 2002-2016. Int J Environ Res Public Health 2019;16:E4531. [PMID: 31731820 DOI: 10.3390/ijerph16224531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
68 Saso A, Kampmann B, Roetynck S. Vaccine-Induced Cellular Immunity against Bordetella pertussis: Harnessing Lessons from Animal and Human Studies to Improve Design and Testing of Novel Pertussis Vaccines. Vaccines (Basel) 2021;9:877. [PMID: 34452002 DOI: 10.3390/vaccines9080877] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Rubin K, Glazer S. The pertussis hypothesis: Bordetella pertussis colonization in the etiology of asthma and diseases of allergic sensitization. Med Hypotheses 2018;120:101-15. [PMID: 30220328 DOI: 10.1016/j.mehy.2018.08.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
70 Loconsole D, De Robertis AL, Morea A, Metallo A, Lopalco PL, Chironna M. Resurgence of Pertussis and Emergence of the Ptxp3 Toxin Promoter Allele in South Italy. Pediatr Infect Dis J 2018;37:e126-31. [PMID: 28945679 DOI: 10.1097/INF.0000000000001804] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
71 Domenech de Cellès M, Riolo MA, Magpantay FM, Rohani P, King AA. Epidemiological evidence for herd immunity induced by acellular pertussis vaccines. Proc Natl Acad Sci U S A 2014;111:E716-7. [PMID: 24516173 DOI: 10.1073/pnas.1323795111] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 3.8] [Reference Citation Analysis]
72 Naninck T, Coutte L, Mayet C, Contreras V, Locht C, Le Grand R, Chapon C. In vivo imaging of bacterial colonization of the lower respiratory tract in a baboon model of Bordetella pertussis infection and transmission. Sci Rep 2018;8:12297. [PMID: 30115990 DOI: 10.1038/s41598-018-30896-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
73 Locht C, Mielcarek N. Live attenuated vaccines against pertussis. Expert Rev Vaccines 2014;13:1147-58. [PMID: 25085735 DOI: 10.1586/14760584.2014.942222] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
74 Sedighi I, Karimi A, Amanati A. Old Disease and New Challenges: Major Obstacles of Current Strategies in the Prevention of Pertussis. Iran J Pediatr 2016;26:e5514. [PMID: 27729960 DOI: 10.5812/ijp.5514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
75 Eby JC, Gray MC, Warfel JM, Merkel TJ, Hewlett EL. Use of a Toxin Neutralization Assay To Characterize the Serologic Response to Adenylate Cyclase Toxin after Infection with Bordetella pertussis. Clin Vaccine Immunol 2017;24:e00370-16. [PMID: 27760780 DOI: 10.1128/CVI.00370-16] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
76 Melvin JA, Scheller EV, Noël CR, Cotter PA. New Insight into Filamentous Hemagglutinin Secretion Reveals a Role for Full-Length FhaB in Bordetella Virulence. mBio 2015;6:e01189-15. [PMID: 26286694 DOI: 10.1128/mBio.01189-15] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
77 Wang P, Huo C, Lang S, Caution K, Nick ST, Dubey P, Deora R, Huang X. Chemical Synthesis and Immunological Evaluation of a Pentasaccharide Bearing Multiple Rare Sugars as a Potential Anti‐pertussis Vaccine. Angew Chem 2020;132:6513-20. [DOI: 10.1002/ange.201915913] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 4.5] [Reference Citation Analysis]
78 Bottero D, Gaillard ME, Zurita E, Moreno G, Martinez DS, Bartel E, Bravo S, Carriquiriborde F, Errea A, Castuma C, Rumbo M, Hozbor D. Characterization of the immune response induced by pertussis OMVs-based vaccine. Vaccine 2016;34:3303-9. [PMID: 27151884 DOI: 10.1016/j.vaccine.2016.04.079] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
79 Dubois V, Locht C. Mucosal Immunization Against Pertussis: Lessons From the Past and Perspectives. Front Immunol 2021;12:701285. [PMID: 34211481 DOI: 10.3389/fimmu.2021.701285] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
80 Citron MP, McAnulty J, Callahan C, Knapp W, Fontenot J, Morales P, Flynn JA, Douglas CM, Espeseth AS. Transplacental Antibody Transfer of Respiratory Syncytial Virus Specific IgG in Non-Human Primate Mother-Infant Pairs. Pathogens 2021;10:1441. [PMID: 34832599 DOI: 10.3390/pathogens10111441] [Reference Citation Analysis]
81 Bruno C, Agnolon V, Berti F, Bufali S, O'Hagan DT, Baudner BC. The preparation and characterization of PLG nanoparticles with an entrapped synthetic TLR7 agonist and their preclinical evaluation as adjuvant for an adsorbed DTaP vaccine. Eur J Pharm Biopharm 2016;105:1-8. [PMID: 27224856 DOI: 10.1016/j.ejpb.2016.05.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
82 Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ. Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev 2016;29:449-86. [PMID: 27029594 DOI: 10.1128/CMR.00083-15] [Cited by in Crossref: 177] [Cited by in F6Publishing: 83] [Article Influence: 29.5] [Reference Citation Analysis]
83 Siegrist C. Vaccine Immunology. Plotkin's Vaccines. Elsevier; 2018. pp. 16-34.e7. [DOI: 10.1016/b978-0-323-35761-6.00002-x] [Cited by in Crossref: 26] [Article Influence: 6.5] [Reference Citation Analysis]
84 Moon K, Bonocora RP, Kim DD, Chen Q, Wade JT, Stibitz S, Hinton DM. The BvgAS Regulon of Bordetella pertussis. mBio 2017;8:e01526-17. [PMID: 29018122 DOI: 10.1128/mBio.01526-17] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
85 Cole LE, Zhang J, Pacheco KM, Lhéritier P, Anosova NG, Piolat J, Zheng L, Reveneau N. Immunological Distinctions between Acellular and Whole-Cell Pertussis Immunizations of Baboons Persist for at Least One Year after Acellular Vaccine Boosting. Vaccines (Basel) 2020;8:E729. [PMID: 33276673 DOI: 10.3390/vaccines8040729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Kovitwanichkanont T. Public health measures for pertussis prevention and control. Australian and New Zealand Journal of Public Health 2017;41:557-60. [DOI: 10.1111/1753-6405.12732] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
87 Marchant A, Sadarangani M, Garand M, Dauby N, Verhasselt V, Pereira L, Bjornson G, Jones CE, Halperin SA, Edwards KM, Heath P, Openshaw PJ, Scheifele DW, Kollmann TR. Maternal immunisation: collaborating with mother nature. Lancet Infect Dis 2017;17:e197-208. [PMID: 28433705 DOI: 10.1016/S1473-3099(17)30229-3] [Cited by in Crossref: 75] [Cited by in F6Publishing: 45] [Article Influence: 15.0] [Reference Citation Analysis]
88 Chen Z, He Q. Immune persistence after pertussis vaccination. Hum Vaccin Immunother 2017;13:744-56. [PMID: 28045580 DOI: 10.1080/21645515.2016.1259780] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
89 Wang X, Gao N, Wen J, Li J, Ma Y, Sun M, Liang J, Shi L. Immunogenicity of a Candidate DTacP-sIPV Combined Vaccine and Its Protection Efficacy against Pertussis in a Rhesus Macaque Model. Vaccines (Basel) 2021;10:47. [PMID: 35062708 DOI: 10.3390/vaccines10010047] [Reference Citation Analysis]
90 Wilson CB, Karp CL. Can immunological principles and cross-disciplinary science illuminate the path to vaccines for HIV and other global health challenges? Philos Trans R Soc Lond B Biol Sci 2015;370:20140152. [PMID: 25964461 DOI: 10.1098/rstb.2014.0152] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
91 Versteegen P, Berbers GAM, Smits G, Sanders EAM, van der Klis FRM, de Melker HE, van der Maas NAT. More than 10 years after introduction of an acellular pertussis vaccine in infancy: a cross-sectional serosurvey of pertussis in the Netherlands. Lancet Reg Health Eur 2021;10:100196. [PMID: 34806066 DOI: 10.1016/j.lanepe.2021.100196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
92 de Gouw D, de Jonge MI, Hermans PW, Wessels HJ, Zomer A, Berends A, Pratt C, Berbers GA, Mooi FR, Diavatopoulos DA. Proteomics-identified Bvg-activated autotransporters protect against bordetella pertussis in a mouse model. PLoS One 2014;9:e105011. [PMID: 25133400 DOI: 10.1371/journal.pone.0105011] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
93 Dorji D, Mooi F, Yantorno O, Deora R, Graham RM, Mukkur TK. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance. Med Microbiol Immunol 2018;207:3-26. [PMID: 29164393 DOI: 10.1007/s00430-017-0524-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
94 Lambert EE, Buisman AM, van Els CACM. Superior B. pertussis Specific CD4+ T-Cell Immunity Imprinted by Natural Infection. Adv Exp Med Biol 2019;1183:81-98. [PMID: 31321753 DOI: 10.1007/5584_2019_405] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
95 Gestal MC, Rivera I, Howard LK, Dewan KK, Soumana IH, Dedloff M, Nicholson TL, Linz B, Harvill ET. Blood or Serum Exposure Induce Global Transcriptional Changes, Altered Antigenic Profile, and Increased Cytotoxicity by Classical Bordetellae. Front Microbiol 2018;9:1969. [PMID: 30245672 DOI: 10.3389/fmicb.2018.01969] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
96 Sealey KL, Harris SR, Fry NK, Hurst LD, Gorringe AR, Parkhill J, Preston A. Genomic Analysis of Isolates From the United Kingdom 2012 Pertussis Outbreak Reveals That Vaccine Antigen Genes Are Unusually Fast Evolving. J Infect Dis 2015;212:294-301. [DOI: 10.1093/infdis/jiu665] [Cited by in Crossref: 49] [Cited by in F6Publishing: 47] [Article Influence: 6.1] [Reference Citation Analysis]
97 Warfel JM, Merkel TJ. The baboon model of pertussis: effective use and lessons for pertussis vaccines. Expert Review of Vaccines 2014;13:1241-52. [DOI: 10.1586/14760584.2014.946016] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 4.8] [Reference Citation Analysis]
98 Carbonetti NH, Wirsing von König CH, Lan R, Jacob-Dubuisson F, Cotter PA, Deora R, Merkel TJ, van Els CA, Locht C, Hozbor D, Rodriguez ME. Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development. Clin Vaccine Immunol 2016;23:842-50. [PMID: 27655886 DOI: 10.1128/CVI.00388-16] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
99 Bernard NJ, Finlay CM, Tannahill GM, Cassidy JP, O'Neill LA, Mills KH. A critical role for the TLR signaling adapter Mal in alveolar macrophage-mediated protection against Bordetella pertussis. Mucosal Immunol 2015;8:982-92. [PMID: 25515629 DOI: 10.1038/mi.2014.125] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
100 Wilk MM, Mills KHG. CD4 TRM Cells Following Infection and Immunization: Implications for More Effective Vaccine Design. Front Immunol 2018;9:1860. [PMID: 30147701 DOI: 10.3389/fimmu.2018.01860] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
101 Bolotin S, Harvill ET, Crowcroft NS. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine. Pathog Dis 2015;73:ftv057. [PMID: 26253079 DOI: 10.1093/femspd/ftv057] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
102 Locht C, Antoine R. The History of Pertussis Toxin. Toxins (Basel) 2021;13:623. [PMID: 34564627 DOI: 10.3390/toxins13090623] [Reference Citation Analysis]
103 Zimmerman LI, Papin JF, Warfel J, Wolf RF, Kosanke SD, Merkel TJ. Histopathology of Bordetella pertussis in the Baboon Model. Infect Immun 2018;86:e00511-18. [PMID: 30126900 DOI: 10.1128/IAI.00511-18] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
104 Patrick KL, Bell SL, Weindel CG, Watson RO. Exploring the "Multiple-Hit Hypothesis" of Neurodegenerative Disease: Bacterial Infection Comes Up to Bat. Front Cell Infect Microbiol 2019;9:138. [PMID: 31192157 DOI: 10.3389/fcimb.2019.00138] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 8.7] [Reference Citation Analysis]
105 Domenech de Cellès M, Rohani P, King AA. Duration of Immunity and Effectiveness of Diphtheria-Tetanus-Acellular Pertussis Vaccines in Children. JAMA Pediatr 2019;173:588-94. [PMID: 31009031 DOI: 10.1001/jamapediatrics.2019.0711] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
106 den Hartog G, Schijf MA, Berbers GAM, van der Klis FRM, Buisman AM. Bordetella pertussis induces IFN-γ production by NK cells resulting in chemo-attraction by respiratory epithelial cells. J Infect Dis 2020:jiaa140. [PMID: 32219323 DOI: 10.1093/infdis/jiaa140] [Reference Citation Analysis]
107 Ikematsu H, Kawai N, Yajima S. A cross sectional survey measuring sero-incidence of pertussis infection among Japanese junior and senior high school students in 2013 and 2014. Vaccine 2017;35:3859-64. [PMID: 28599792 DOI: 10.1016/j.vaccine.2017.05.082] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
108 Althouse BM, Scarpino SV. Asymptomatic transmission and the resurgence of Bordetella pertussis. BMC Med 2015;13:146. [PMID: 26103968 DOI: 10.1186/s12916-015-0382-8] [Cited by in Crossref: 131] [Cited by in F6Publishing: 114] [Article Influence: 18.7] [Reference Citation Analysis]
109 Goldstein E, Worby CJ, Lipsitch M. On the Role of Different Age Groups and Pertussis Vaccines During the 2012 Outbreak in Wisconsin. Open Forum Infect Dis 2018;5:ofy082. [PMID: 29942818 DOI: 10.1093/ofid/ofy082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
110 de Graaf H, Ibrahim M, Hill AR, Gbesemete D, Vaughan AT, Gorringe A, Preston A, Buisman AM, Faust SN, Kester KE, Berbers GAM, Diavatopoulos DA, Read RC. Controlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing Colonization. Clin Infect Dis 2020;71:403-11. [PMID: 31562530 DOI: 10.1093/cid/ciz840] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
111 Hall JM, Bitzer GJ, DeJong MA, Kang J, Wong TY, Wolf MA, Bevere JR, Barbier M, Damron FH. Mucosal Immunization with DTaP Confers Protection against Bordetella pertussis Infection and Cough in Sprague-Dawley Rats. Infect Immun 2021;89:e0034621. [PMID: 34516235 DOI: 10.1128/IAI.00346-21] [Reference Citation Analysis]
112 Leuridan E. Pertussis vaccination in pregnancy: State of the art. Vaccine 2017;35:4453-6. [PMID: 28359620 DOI: 10.1016/j.vaccine.2017.03.061] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
113 Vaure C, Grégoire-Barou V, Courtois V, Chautard E, Dégletagne C, Liu Y. Göttingen Minipigs as a Model to Evaluate Longevity, Functionality, and Memory of Immune Response Induced by Pertussis Vaccines. Front Immunol 2021;12:613810. [PMID: 33815369 DOI: 10.3389/fimmu.2021.613810] [Reference Citation Analysis]
114 Ausiello CM, Cassone A. Acellular pertussis vaccines and pertussis resurgence: revise or replace? mBio 2014;5:e01339-14. [PMID: 24917600 DOI: 10.1128/mBio.01339-14] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 4.1] [Reference Citation Analysis]
115 Castillo ME, Bada C, Del Aguila O, Petrozzi-Helasvuo V, Casabona-Ore V, Reyes I, Del Valle-Mendoza J. Detection of Bordetella pertussis using a PCR test in infants younger than one year old hospitalized with whooping cough in five Peruvian hospitals. Int J Infect Dis 2015;41:36-41. [PMID: 26523641 DOI: 10.1016/j.ijid.2015.10.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
116 Edwards KM, Decker MD. Pertussis Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 711-761.e16. [DOI: 10.1016/b978-0-323-35761-6.00043-2] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
117 Yasui Y, Mitsui T, Nishimura T, Uchida K, Inokuchi M, Mori M, Tokumura M, Nakayama T. School-age children and adolescents suspected of having been to be infected with pertussis in Japan. Vaccine 2018;36:2910-5. [DOI: 10.1016/j.vaccine.2018.01.048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
118 Gentile A, Bricks L, Ávila-Agüero ML, Kfouri RA, Torres JP, Ulloa-Gutierrez R, Glover RE, Sarti E. Pertussis in Latin America and the Hispanic Caribbean: a systematic review. Expert Rev Vaccines 2019;18:829-45. [PMID: 31317794 DOI: 10.1080/14760584.2019.1643241] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
119 Doroshenko A, Qian W, Osgood ND. Evaluation of outbreak response immunization in the control of pertussis using agent-based modeling. PeerJ 2016;4:e2337. [PMID: 27602299 DOI: 10.7717/peerj.2337] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
120 Blain AE, Lewis M, Banerjee E, Kudish K, Liko J, McGuire S, Selvage D, Watt J, Martin SW, Skoff TH. An Assessment of the Cocooning Strategy for Preventing Infant Pertussis-United States, 2011. Clin Infect Dis 2016;63:S221-6. [PMID: 27838676 DOI: 10.1093/cid/ciw528] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
121 Craig R, Kunkel E, Crowcroft NS, Fitzpatrick MC, de Melker H, Althouse BM, Merkel T, Scarpino SV, Koelle K, Friedman L, Arnold C, Bolotin S. Asymptomatic Infection and Transmission of Pertussis in Households: A Systematic Review. Clin Infect Dis 2020;70:152-61. [PMID: 31257450 DOI: 10.1093/cid/ciz531] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
122 Eberhardt CS, Siegrist CA. What Is Wrong with Pertussis Vaccine Immunity? Inducing and Recalling Vaccine-Specific Immunity. Cold Spring Harb Perspect Biol 2017;9:a029629. [PMID: 28289058 DOI: 10.1101/cshperspect.a029629] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
123 Nakamura K, Shinoda N, Hiramatsu Y, Ohnishi S, Kamitani S, Ogura Y, Hayashi T, Horiguchi Y. BspR/BtrA, an Anti-σ Factor, Regulates the Ability of Bordetella bronchiseptica To Cause Cough in Rats. mSphere 2019;4:e00093-19. [PMID: 31019000 DOI: 10.1128/mSphere.00093-19] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
124 van der Lee S, Hendrikx LH, Sanders EAM, Berbers GAM, Buisman AM. Whole-Cell or Acellular Pertussis Primary Immunizations in Infancy Determines Adolescent Cellular Immune Profiles. Front Immunol 2018;9:51. [PMID: 29416544 DOI: 10.3389/fimmu.2018.00051] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
125 Martin SW, Pawloski L, Williams M, Weening K, DeBolt C, Qin X, Reynolds L, Kenyon C, Giambrone G, Kudish K, Miller L, Selvage D, Lee A, Skoff TH, Kamiya H, Cassiday PK, Tondella ML, Clark TA. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis 2015;60:223-7. [PMID: 25301209 DOI: 10.1093/cid/ciu788] [Cited by in Crossref: 124] [Cited by in F6Publishing: 106] [Article Influence: 15.5] [Reference Citation Analysis]
126 Forghani H, Jamshidi Makiani M, Zarei Jaliani H, Boustanshenas M, Zahraei SM. Recombinant Production of a Novel Fusion Protein: Listeriolysin O Fragment Fused to S1 Subunit of Pertussis Toxin. Iran Biomed J 2021;25:33-40. [PMID: 33129237 DOI: 10.29252/ibj.25.1.33] [Reference Citation Analysis]
127 Leung T, Campbell PT, Hughes BD, Frascoli F, McCaw JM. Infection-acquired versus vaccine-acquired immunity in an SIRWS model. Infect Dis Model 2018;3:118-35. [PMID: 30839933 DOI: 10.1016/j.idm.2018.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
128 Poolman JT. Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections. NPJ Vaccines 2020;5:84. [PMID: 32963814 DOI: 10.1038/s41541-020-00232-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
129 Liang JL, Tiwari T, Moro P, Messonnier NE, Reingold A, Sawyer M, Clark TA. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2018;67:1-44. [PMID: 29702631 DOI: 10.15585/mmwr.rr6702a1] [Cited by in Crossref: 146] [Cited by in F6Publishing: 123] [Article Influence: 36.5] [Reference Citation Analysis]
130 Choi YH, Campbell H, Amirthalingam G, van Hoek AJ, Miller E. Investigating the pertussis resurgence in England and Wales, and options for future control. BMC Med 2016;14:121. [PMID: 27580649 DOI: 10.1186/s12916-016-0665-8] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
131 Preston A. The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development. Hum Vaccin Immunother 2016;12:1274-6. [PMID: 26889694 DOI: 10.1080/21645515.2015.1137402] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
132 Esposito S, Stefanelli P, Fry NK, Fedele G, He Q, Paterson P, Tan T, Knuf M, Rodrigo C, Weil Olivier C, Flanagan KL, Hung I, Lutsar I, Edwards K, O'Ryan M, Principi N; World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Vaccine Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EVASG). Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines. Front Immunol 2019;10:1344. [PMID: 31333640 DOI: 10.3389/fimmu.2019.01344] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 12.3] [Reference Citation Analysis]
133 Tang X, Tang T, Yan R, Zhou Y, Deng X, He H. Intention to accept pertussis vaccination among Chinese people older than age 5. Hum Vaccin Immunother 2021;17:1686-92. [PMID: 33449818 DOI: 10.1080/21645515.2020.1849517] [Reference Citation Analysis]
134 Vaughan TE, Pratt CB, Sealey K, Preston A, Fry NK, Gorringe AR. Plasticity of fimbrial genotype and serotype within populations of Bordetella pertussis: analysis by paired flow cytometry and genome sequencing. Microbiology 2014;160:2030-44. [DOI: 10.1099/mic.0.079251-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
135 Domenech de Cellès M, Magpantay FM, King AA, Rohani P. The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc Biol Sci 2016;283:20152309. [PMID: 26763701 DOI: 10.1098/rspb.2015.2309] [Cited by in Crossref: 63] [Cited by in F6Publishing: 61] [Article Influence: 10.5] [Reference Citation Analysis]
136 Aibani N, Patel P, Buchanan R, Strom S, Wasan KM, Hancock REW, Gerdts V, Wasan EK. Assessing the In Vivo Effectiveness of Cationic Lipid Nanoparticles with a Triple Adjuvant for Intranasal Vaccination against the Respiratory Pathogen Bordetella pertussis. Mol Pharm 2022. [PMID: 35302764 DOI: 10.1021/acs.molpharmaceut.1c00852] [Reference Citation Analysis]
137 Rumbo M, Hozbor D. Development of improved pertussis vaccine. Hum Vaccin Immunother 2014;10:2450-3. [PMID: 25424954 DOI: 10.4161/hv.29253] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
138 He H, Yao P, Zhou Y, Deng X, Pan J. Is Pertussis Infection Neglected in China? Evidence from a Seroepidemiology Survey in Zhejiang, an Eastern Province of China. PLoS One 2016;11:e0155965. [PMID: 27223467 DOI: 10.1371/journal.pone.0155965] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
139 Guiso N. Pertussis vaccination and whooping cough: and now what? Expert Review of Vaccines 2014;13:1163-5. [DOI: 10.1586/14760584.2014.941816] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
140 Dunne A, Mielke LA, Allen AC, Sutton CE, Higgs R, Cunningham CC, Higgins SC, Mills KHG. A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine. Mucosal Immunol 2015;8:607-17. [DOI: 10.1038/mi.2014.93] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 5.3] [Reference Citation Analysis]
141 Perez Chacon G, Ramsay J, Brennan-Jones CG, Estcourt MJ, Richmond P, Holt P, Snelling T. Whole-cell pertussis vaccine in early infancy for the prevention of allergy in children. Cochrane Database Syst Rev 2021;9:CD013682. [PMID: 34693993 DOI: 10.1002/14651858.CD013682.pub2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
142 Hegerle N, Guiso N. Bordetella pertussis and pertactin-deficient clinical isolates: lessons for pertussis vaccines. Expert Review of Vaccines 2014;13:1135-46. [DOI: 10.1586/14760584.2014.932254] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
143 Hughes MM, Englund JA, Edwards K, Yoder S, Tielsch JM, Steinhoff M, Khatry SK, LeClerq SC, Katz J. Pertussis seroepidemiology in women and their infants in Sarlahi District, Nepal. Vaccine 2017;35:6766-73. [PMID: 29037576 DOI: 10.1016/j.vaccine.2017.09.074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
144 Jõgi P, Oona M, Toompere K, Leedo S, Epstein J, Lutsar I. Seroprevalence of IgG antibodies to pertussis toxin in children and adolescents in Estonia. Vaccine 2014;32:5311-5. [DOI: 10.1016/j.vaccine.2014.07.066] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
145 Gutiérrez-Ferman JL, Villarreal-Treviño L, Ramírez-Aranda JM, Camacho-Ortiz A, Ballesteros-Elizondo MR, Moreno-Juárez MR, Mendoza-Olazarán S, de la O Cavazos ME, Villarreal-Pérez JZ, Gómez-Govea MA, Garza-González E. Emerging of ptxP3 lineage in Bordetella pertussis strains circulating in a population in northeastern Mexico. Epidemiol Infect 2018;146:2096-101. [PMID: 30136639 DOI: 10.1017/S0950268818002303] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
146 Salyer ACD, David SA. Transcriptomal signatures of vaccine adjuvants and accessory immunostimulation of sentinel cells by toll-like receptor 2/6 agonists. Hum Vaccin Immunother 2018;14:1686-96. [PMID: 29852079 DOI: 10.1080/21645515.2018.1480284] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
147 Yentongchai M, Thamwiriyasati N, Imtong C, Li HC, Angsuthanasombat C. Preferential modification of CyaA-hemolysin by CyaC-acyltransferase through the catalytic Ser30-His33 dyad in esterolysis of palmitoyl-donor substrate devoid of acyl carrier proteins. Arch Biochem Biophys 2020;694:108615. [PMID: 33011179 DOI: 10.1016/j.abb.2020.108615] [Reference Citation Analysis]
148 Ausiello CM, Mascart F, Corbière V, Fedele G. Human Immune Responses to Pertussis Vaccines. Adv Exp Med Biol 2019;1183:99-113. [PMID: 31342460 DOI: 10.1007/5584_2019_406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Rodrigues CMC, Pinto MV, Sadarangani M, Plotkin SA. Whither vaccines? J Infect 2017;74 Suppl 1:S2-9. [PMID: 28646957 DOI: 10.1016/S0163-4453(17)30184-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
150 de Graaf H, Gbesemete D, Gorringe AR, Diavatopoulos DA, Kester KE, Faust SN, Read RC. Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model. BMJ Open 2017;7:e018594. [PMID: 29025851 DOI: 10.1136/bmjopen-2017-018594] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
151 Tomas J, Koo Y, Popoff D, Arce-Gorvel V, Hanniffy S, Gorvel JP, Mionnet C. PTX Instructs the Development of Lung-Resident Memory T Cells in Bordetella pertussis Infected Mice. Toxins (Basel) 2021;13:632. [PMID: 34564636 DOI: 10.3390/toxins13090632] [Reference Citation Analysis]
152 DeAngelis H, Scarpino SV, Fitzpatrick MC, Galvani AP, Althouse BM. Epidemiological and Economic Effects of Priming With the Whole-Cell Bordetella pertussis Vaccine. JAMA Pediatr 2016;170:459-65. [PMID: 27018830 DOI: 10.1001/jamapediatrics.2016.0047] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
153 Jõgi P, Oona M, Toompere K, Lutsar I. Estimated and reported incidence of pertussis in Estonian adults: A seroepidemiological study. Vaccine 2015;33:4756-61. [DOI: 10.1016/j.vaccine.2015.08.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
154 Boehm DT, Hall JM, Wong TY, DiVenere AM, Sen-Kilic E, Bevere JR, Bradford SD, Blackwood CB, Elkins CM, DeRoos KA, Gray MC, Cooper CG, Varney ME, Maynard JA, Hewlett EL, Barbier M, Damron FH. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice. Infect Immun 2018;86:e00857-17. [PMID: 30012638 DOI: 10.1128/IAI.00857-17] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
155 Johnson RM, Nash ZM, Dedloff MR, Shook JC, Cotter PA. DegP Initiates Regulated Processing of Filamentous Hemagglutinin in Bordetella bronchiseptica. mBio 2021;12:e0146521. [PMID: 34182780 DOI: 10.1128/mBio.01465-21] [Reference Citation Analysis]
156 Le Saux N, Gemmill I. Reining in the "100-day cough": unfinished business. CMAJ 2016;188:1135-6. [PMID: 27672221 DOI: 10.1503/cmaj.161048] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
157 Madhi SA, Nunes MC. Experience and challenges on influenza and pertussis vaccination in pregnant women. Hum Vaccin Immunother 2018;14:2183-8. [PMID: 30024822 DOI: 10.1080/21645515.2018.1483810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
158 Fine PE, Mulholland K, Scott JA, Edmunds WJ. Community Protection. Plotkin's Vaccines. Elsevier; 2018. pp. 1512-1531.e5. [DOI: 10.1016/b978-0-323-35761-6.00077-8] [Cited by in Crossref: 10] [Article Influence: 2.5] [Reference Citation Analysis]
159 Esposito S, Principi N. Prevention of pertussis: An unresolved problem. Hum Vaccin Immunother 2018;14:2452-9. [PMID: 29856680 DOI: 10.1080/21645515.2018.1480298] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
160 Pajon R, Buckwalter CM, Johswich KO, Gray-Owen SD, Granoff DM. A native outer membrane vesicle vaccine confers protection against meningococcal colonization in human CEACAM1 transgenic mice. Vaccine 2015;33:1317-23. [PMID: 25662856 DOI: 10.1016/j.vaccine.2015.01.057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
161 Valli E, Harriett AJ, Nowakowska MK, Baudier RL, Provosty WB, McSween Z, Lawson LB, Nakanishi Y, Norton EB. LTA1 is a safe, intranasal enterotoxin-based adjuvant that improves vaccine protection against influenza in young, old and B-cell-depleted (μMT) mice. Sci Rep 2019;9:15128. [PMID: 31641151 DOI: 10.1038/s41598-019-51356-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
162 Warfel JM, Zimmerman LI, Merkel TJ. Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis. Clin Vaccine Immunol 2016;23:47-54. [PMID: 26561389 DOI: 10.1128/CVI.00449-15] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
163 Locht C. Will we have new pertussis vaccines? Vaccine 2018;36:5460-9. [PMID: 29180031 DOI: 10.1016/j.vaccine.2017.11.055] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
164 Cassone A. Pertussis Vaccines and Vaccination Strategies. An Ever-Challenging Health Problem. Adv Exp Med Biol 2019;1183:161-7. [PMID: 31342457 DOI: 10.1007/5584_2019_411] [Reference Citation Analysis]
165 Kandeil W, Atanasov P, Avramioti D, Fu J, Demarteau N, Li X. The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review. Expert Rev Vaccines 2019;18:439-55. [PMID: 30887849 DOI: 10.1080/14760584.2019.1588727] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
166 Scott S, van der Sande M, Faye-Joof T, Mendy M, Sanneh B, Barry Jallow F, de Melker H, van der Klis F, van Gageldonk P, Mooi F, Kampmann B. Seroprevalence of pertussis in the Gambia: evidence for continued circulation of bordetella pertussis despite high vaccination rates. Pediatr Infect Dis J 2015;34:333-8. [PMID: 25764094 DOI: 10.1097/INF.0000000000000576] [Cited by in Crossref: 29] [Cited by in F6Publishing: 16] [Article Influence: 4.1] [Reference Citation Analysis]
167 Nguyen AW, Wagner EK, Laber JR, Goodfield LL, Smallridge WE, Harvill ET, Papin JF, Wolf RF, Padlan EA, Bristol A, Kaleko M, Maynard JA. A cocktail of humanized anti-pertussis toxin antibodies limits disease in murine and baboon models of whooping cough. Sci Transl Med 2015;7:316ra195. [PMID: 26631634 DOI: 10.1126/scitranslmed.aad0966] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
168 Jayasundara D, Lee E, Octavia S, Lan R, Tanaka MM, Wood JG. Emergence of pertactin-deficient pertussis strains in Australia can be explained by models of vaccine escape. Epidemics 2020;31:100388. [DOI: 10.1016/j.epidem.2020.100388] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
169 Brookes C, Freire-Martin I, Cavell B, Alexander F, Taylor S, Persaud R, Fry N, Preston A, Diavatopoulos D, Gorringe A. Bordetella pertussis isolates vary in their interactions with human complement components. Emerg Microbes Infect 2018;7:81. [PMID: 29739922 DOI: 10.1038/s41426-018-0084-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
170 Warfel JM, Edwards KM. Pertussis vaccines and the challenge of inducing durable immunity. Current Opinion in Immunology 2015;35:48-54. [DOI: 10.1016/j.coi.2015.05.008] [Cited by in Crossref: 62] [Cited by in F6Publishing: 48] [Article Influence: 8.9] [Reference Citation Analysis]
171 de Jonge EF, Balhuizen MD, van Boxtel R, Wu J, Haagsman HP, Tommassen J. Heat shock enhances outer-membrane vesicle release in Bordetella spp. Current Research in Microbial Sciences 2021;2:100009. [DOI: 10.1016/j.crmicr.2020.100009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
172 Gaillard ME, Bottero D, Moreno G, Rumbo M, Hozbor D. Strategies and new developments to control pertussis, an actual health problem. Pathog Dis. 2015;73:ftv059. [PMID: 26260328 DOI: 10.1093/femspd/ftv059] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
173 Pinto MV, Merkel TJ. Pertussis disease and transmission and host responses: insights from the baboon model of pertussis. J Infect 2017;74 Suppl 1:S114-9. [PMID: 28646950 DOI: 10.1016/S0163-4453(17)30201-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
174 Safarchi A, Octavia S, Luu LD, Tay CY, Sintchenko V, Wood N, Marshall H, McIntyre P, Lan R. Better colonisation of newly emerged Bordetella pertussis in the co-infection mouse model study. Vaccine 2016;34:3967-71. [PMID: 27346304 DOI: 10.1016/j.vaccine.2016.06.052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
175 Soltani MS, Noofeli M, Banihashemi SR, Shahcheraghi F, Eftekhar F. Evaluation of Outer Membrane Vesicles Obtained from Predominant Local Isolate of Boredetella pertussis as a Vaccine Candidate. Iran Biomed J 2021;25:399-407. [PMID: 34719226 DOI: 10.52547/ibj.25.6.399] [Reference Citation Analysis]
176 Lipsitch M, Siber GR, Klugman KP, Collier RJ. How Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem? mBio 2016;7. [DOI: 10.1128/mbio.00428-16] [Cited by in Crossref: 101] [Cited by in F6Publishing: 61] [Article Influence: 16.8] [Reference Citation Analysis]
177 Orr MT, Khandhar AP, Seydoux E, Liang H, Gage E, Mikasa T, Beebe EL, Rintala ND, Persson KH, Ahniyaz A, Carter D, Reed SG, Fox CB. Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology. NPJ Vaccines 2019;4:1. [PMID: 30622742 DOI: 10.1038/s41541-018-0094-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
178 Gill C, Rohani P, Thea DM. The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis. F1000Res 2017;6:1568. [PMID: 28928960 DOI: 10.12688/f1000research.11654.1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
179 Gestal MC, Johnson HM, Harvill ET. Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections. Front Immunol 2019;10:2869. [PMID: 31921136 DOI: 10.3389/fimmu.2019.02869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
180 Sheridan SL, Frith K, Snelling TL, Grimwood K, Mcintyre PB, Lambert SB. Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology. Expert Review of Vaccines 2014;13:1081-106. [DOI: 10.1586/14760584.2014.944167] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 9.5] [Reference Citation Analysis]
181 Zeddeman A, van Schuppen E, Kok KE, van Gent M, Heuvelman KJ, Bart MJ, van der Heide HGJ, Gillard J, Simonetti E, Eleveld MJ, van Opzeeland FJH, van Selm S, de Groot R, de Jonge MI, Mooi FR, Diavatopoulos DA. Effect of FHA and Prn on Bordetella pertussis colonization of mice is dependent on vaccine type and anatomical site. PLoS One 2020;15:e0237394. [PMID: 32822419 DOI: 10.1371/journal.pone.0237394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
182 Zhang F, Ledue O, Jun M, Goulart C, Malley R, Lu YJ. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms. mBio 2018;9:e01949-18. [PMID: 30327437 DOI: 10.1128/mBio.01949-18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
183 Starost LJ, Karassek S, Sano Y, Kanda T, Kim KS, Dobrindt U, Rüter C, Schmidt MA. Pertussis Toxin Exploits Host Cell Signaling Pathways Induced by Meningitis-Causing E. coli K1-RS218 and Enhances Adherence of Monocytic THP-1 Cells to Human Cerebral Endothelial Cells. Toxins (Basel) 2016;8:E291. [PMID: 27754355 DOI: 10.3390/toxins8100291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
184 Dewan KK, Taylor-Mulneix DL, Hilburger LJ, Rivera I, Preston A, Harvill ET. An Extracellular Polysaccharide Locus Required for Transmission of Bordetella bronchiseptica. J Infect Dis 2017;216:899-906. [PMID: 28973366 DOI: 10.1093/infdis/jix251] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
185 Zerbo O, Bartlett J, Goddard K, Fireman B, Lewis E, Klein NP. Acellular Pertussis Vaccine Effectiveness Over Time. Pediatrics 2019;144:e20183466. [PMID: 31182549 DOI: 10.1542/peds.2018-3466] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
186 Gestal MC, Howard LK, Dewan K, Johnson HM, Barbier M, Bryant C, Soumana IH, Rivera I, Linz B, Blas-Machado U, Harvill ET. Enhancement of immune response against Bordetella spp. by disrupting immunomodulation. Sci Rep 2019;9:20261. [PMID: 31889098 DOI: 10.1038/s41598-019-56652-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
187 Saadatian-Elahi M, Plotkin S, Mills KHG, Halperin SA, McIntyre PB, Picot V, Louis J, Johnson DR. Pertussis: Biology, epidemiology and prevention. Vaccine 2016;34:5819-26. [PMID: 27780629 DOI: 10.1016/j.vaccine.2016.10.029] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
188 Rubin K, Glazer S. The pertussis hypothesis: Bordetella pertussis colonization in the pathogenesis of Alzheimer’s disease. Immunobiology 2017;222:228-40. [DOI: 10.1016/j.imbio.2016.09.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
189 Butler SE, Crowley AR, Natarajan H, Xu S, Weiner JA, Bobak CA, Mattox DE, Lee J, Wieland-Alter W, Connor RI, Wright PF, Ackerman ME. Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals. Front Immunol 2020;11:618685. [PMID: 33584712 DOI: 10.3389/fimmu.2020.618685] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
190 Polinori I, Esposito S. Clinical Findings and Management of Pertussis. Adv Exp Med Biol 2019;1183:151-60. [PMID: 31359365 DOI: 10.1007/5584_2019_410] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
191 Lesne E, Cavell BE, Freire-Martin I, Persaud R, Alexander F, Taylor S, Matheson M, van Els CACM, Gorringe A. Acellular Pertussis Vaccines Induce Anti-pertactin Bactericidal Antibodies Which Drives the Emergence of Pertactin-Negative Strains. Front Microbiol 2020;11:2108. [PMID: 32983069 DOI: 10.3389/fmicb.2020.02108] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
192 Gillard J, van Schuppen E, Diavatopoulos DA. Functional Programming of Innate Immune Cells in Response to Bordetella pertussis Infection and Vaccination. Adv Exp Med Biol 2019;1183:53-80. [PMID: 31432398 DOI: 10.1007/5584_2019_404] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
193 de Martino M. Dismantling the Taboo against Vaccines in Pregnancy. Int J Mol Sci 2016;17:E894. [PMID: 27338346 DOI: 10.3390/ijms17060894] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
194 Havers FP, Moro PL, Hunter P, Hariri S, Bernstein H. Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccines: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2019. MMWR Morb Mortal Wkly Rep 2020;69:77-83. [PMID: 31971933 DOI: 10.15585/mmwr.mm6903a5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
195 Jones DR, Rutan BJ, Wargo AR. Impact of Vaccination and Pathogen Exposure Dosage on Shedding Kinetics of Infectious Hematopoietic Necrosis Virus (IHNV) in Rainbow Trout. J Aquat Anim Health 2020;32:95-108. [PMID: 32443164 DOI: 10.1002/aah.10108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
196 Skoff TH, Blain AE, Watt J, Scherzinger K, McMahon M, Zansky SM, Kudish K, Cieslak PR, Lewis M, Shang N, Martin SW. Impact of the US Maternal Tetanus, Diphtheria, and Acellular Pertussis Vaccination Program on Preventing Pertussis in Infants <2 Months of Age: A Case-Control Evaluation. Clin Infect Dis 2017;65:1977-83. [PMID: 29028938 DOI: 10.1093/cid/cix724] [Cited by in Crossref: 71] [Cited by in F6Publishing: 69] [Article Influence: 17.8] [Reference Citation Analysis]
197 Lavelle EC, McLachlan JB. Editorial overview: Immunomodulation: Striking the right balance: using immunomodulators to target infectious diseases, cancer, and autoimmunity. Curr Opin Pharmacol 2018;41:vii-ix. [PMID: 30139514 DOI: 10.1016/j.coph.2018.07.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
198 Villarino Romero R, Osicka R, Sebo P. Filamentous hemagglutinin of Bordetella pertussis: a key adhesin with immunomodulatory properties? Future Microbiol 2014;9:1339-60. [PMID: 25517899 DOI: 10.2217/fmb.14.77] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
199 Xu Y, Xu E, Liu S, Zheng W, Zhang X, Du J, Zhang X, Wang J, Che X, Gu W, Liu Y. Seroepidemiology of pertussis in Hangzhou, China, during 2009-2017. Hum Vaccin Immunother 2019;15:2564-70. [PMID: 31116637 DOI: 10.1080/21645515.2019.1608130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
200 Raeven RH, Brummelman J, Pennings JL, van der Maas L, Tilstra W, Helm K, van Riet E, Jiskoot W, van Els CA, Han WG, Kersten GF, Metz B. Bordetella pertussis outer membrane vesicle vaccine confers equal efficacy in mice with milder inflammatory responses compared to a whole-cell vaccine. Sci Rep 2016;6:38240. [PMID: 27905535 DOI: 10.1038/srep38240] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
201 Zomer A, Otsuka N, Hiramatsu Y, Kamachi K, Nishimura N, Ozaki T, Poolman J, Geurtsen J. Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines. Microb Genom 2018;4. [PMID: 29771235 DOI: 10.1099/mgen.0.000180] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
202 Diks AM, Versteegen P, Teodosio C, Groenland RJ, de Mooij B, Buisman A, Torres-valle A, Pérez-andrés M, Orfao A, Berbers GAM, van Dongen JJM, Berkowska MA; on behalf of the IMI-2 PERISCOPE Consortium. Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination. Vaccines 2022;10:136. [DOI: 10.3390/vaccines10020136] [Reference Citation Analysis]
203 Warfel JM, Merkel TJ. Reply to Domenech de Cellès et al.: Infection and transmission of pertussis in the baboon model. Proc Natl Acad Sci U S A 2014;111:E718. [PMID: 24693544 DOI: 10.1073/pnas.1324074111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
204 Acquaye-Seedah E, Reczek EE, Russell HH, DiVenere AM, Sandman SO, Collins JH, Stein CA, Whitehead TA, Maynard JA. Characterization of Individual Human Antibodies That Bind Pertussis Toxin Stimulated by Acellular Immunization. Infect Immun 2018;86:e00004-18. [PMID: 29581192 DOI: 10.1128/IAI.00004-18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
205 Wang X, Stapleton JA, Klesmith JR, Hewlett EL, Whitehead TA, Maynard JA. Fine Epitope Mapping of Two Antibodies Neutralizing the Bordetella Adenylate Cyclase Toxin. Biochemistry 2017;56:1324-36. [PMID: 28177609 DOI: 10.1021/acs.biochem.6b01163] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
206 Nicholson TL, Brockmeier SL, Loving CL, Register KB, Kehrli ME Jr, Shore SM. The Bordetella bronchiseptica type III secretion system is required for persistence and disease severity but not transmission in swine. Infect Immun 2014;82:1092-103. [PMID: 24366249 DOI: 10.1128/IAI.01115-13] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
207 Diavatopoulos DA, Edwards KM. What Is Wrong with Pertussis Vaccine Immunity? Why Immunological Memory to Pertussis Is Failing. Cold Spring Harb Perspect Biol 2017;9:a029553. [PMID: 28289059 DOI: 10.1101/cshperspect.a029553] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
208 Herzog C. Changing from whole-cell to acellular pertussis vaccines would trade superior tolerability for inferior protection. Expert Review of Vaccines 2015;14:1065-72. [DOI: 10.1586/14760584.2015.1059759] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
209 Lessler J, Cummings DA. Mechanistic Models of Infectious Disease and Their Impact on Public Health. Am J Epidemiol 2016;183:415-22. [PMID: 26893297 DOI: 10.1093/aje/kww021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 4.5] [Reference Citation Analysis]
210 Carcione D, Regan AK, Tracey L, Mak DB, Gibbs R, Dowse GK, Bulsara M, Effler PV. The impact of parental postpartum pertussis vaccination on infection in infants: A population-based study of cocooning in Western Australia. Vaccine 2015;33:5654-61. [PMID: 26320420 DOI: 10.1016/j.vaccine.2015.08.066] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
211 Plotkin SA. Composition of pertussis vaccine given to infants determines long-term T cell polarization. J Clin Invest 2018;128:3742-4. [PMID: 30080178 DOI: 10.1172/JCI122726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
212 Lambert EE, Corbière V, van Gaans-van den Brink JAM, Duijst M, Venkatasubramanian PB, Simonetti E, Huynen M, Diavatopoulos DD, Versteegen P, Berbers GAM, Mascart F, van Els CACM. Uncovering Distinct Primary Vaccination-Dependent Profiles in Human Bordetella Pertussis Specific CD4+ T-Cell Responses Using a Novel Whole Blood Assay. Vaccines (Basel) 2020;8:E225. [PMID: 32429152 DOI: 10.3390/vaccines8020225] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
213 Valdez HA, Marin Franco JL, Gorgojo JP, Alvarez Hayes J, Balboa L, Fernandez Lahore M, Sasiain MC, Rodriguez ME. Human macrophage polarization shapes B. pertussis intracellular persistence. J Leukoc Biol 2021. [PMID: 34811790 DOI: 10.1002/JLB.4A0521-254R] [Reference Citation Analysis]
214 Locht C. Pertussis: Where did we go wrong and what can we do about it? J Infect 2016;72 Suppl:S34-40. [PMID: 27161992 DOI: 10.1016/j.jinf.2016.04.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
215 Thiriard A, Raze D, Locht C. Diversion of complement-mediated killing by Bordetella. Microbes Infect 2018;20:512-20. [PMID: 29454132 DOI: 10.1016/j.micinf.2018.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
216 PERISCOPE Consortium. PERISCOPE: road towards effective control of pertussis. Lancet Infect Dis 2019;19:e179-86. [PMID: 30503084 DOI: 10.1016/S1473-3099(18)30646-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
217 Lynfield R, Daum RS. The Complexity of the Resurgence of Childhood Vaccine-Preventable Diseases in the United States. Curr Pediatr Rep 2014;2:195-203. [DOI: 10.1007/s40124-014-0052-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
218 Ucieklak K, Koj S, Niedziela T. Conserved Structural Features of Core Oligosaccharides among the Lipopolysaccharides of Respiratory Pathogens from the Genus Bordetella Analyzed Exclusively by NMR Spectroscopy. Int J Mol Sci 2021;22:1029. [PMID: 33494150 DOI: 10.3390/ijms22031029] [Reference Citation Analysis]
219 Beesu M, Caruso G, Salyer AC, Khetani KK, Sil D, Weerasinghe M, Tanji H, Ohto U, Shimizu T, David SA. Structure-Based Design of Human TLR8-Specific Agonists with Augmented Potency and Adjuvanticity. J Med Chem 2015;58:7833-49. [PMID: 26351878 DOI: 10.1021/acs.jmedchem.5b01087] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
220 van der Lee S, Stoof SP, van Ravenhorst MB, van Gageldonk PGM, van der Maas NAT, Sanders EAM, Buisman AM, Berbers GAM. Enhanced Bordetella pertussis acquisition rate in adolescents during the 2012 epidemic in the Netherlands and evidence for prolonged antibody persistence after infection. Euro Surveill 2017;22. [PMID: 29183555 DOI: 10.2807/1560-7917.ES.2017.22.47.17-00011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
221 Plans P, Toledo D, Sala MR, Camps N, Villanova M, Rodríguez R, Alvarez J, Solano R, García-Cenoz M, Barrabeig I, Godoy P, Minguell S. Effectiveness of acellular pertussis vaccination during childhood (<7 years of age) for preventing pertussis in household contacts 1-9 years old in Catalonia and Navarra (Spain). Eur J Clin Microbiol Infect Dis 2016;35:2059-67. [PMID: 27612470 DOI: 10.1007/s10096-016-2766-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
222 da Silva Antunes R, Soldevila F, Pomaznoy M, Babor M, Bennett J, Tian Y, Khalil N, Qian Y, Mandava A, Scheuermann RH, Cortese M, Pulendran B, Petro CD, Gilkes AP, Purcell LA, Sette A, Peters B. A system-view of Bordetella pertussis booster vaccine responses in adults primed with whole-cell versus acellular vaccine in infancy. JCI Insight 2021;6:141023. [PMID: 33690224 DOI: 10.1172/jci.insight.141023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 Kang KR, Huh DH, Kim JA, Kang JH. Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model. BMC Immunol 2021;22:68. [PMID: 34641798 DOI: 10.1186/s12865-021-00457-1] [Reference Citation Analysis]
224 Rex JH, Fernandez Lynch H, Cohen IG, Darrow JJ, Outterson K. Designing development programs for non-traditional antibacterial agents. Nat Commun 2019;10:3416. [PMID: 31366924 DOI: 10.1038/s41467-019-11303-9] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
225 Jahnmatz M, Richert L, al-Tawil N, Storsaeter J, Colin C, Bauduin C, Thalen M, Solovay K, Rubin K, Mielcarek N, Thorstensson R, Locht C, Dager L, Ekholm N, Gustafsson M, Linde Å, Lång C, Nastase M, Reinholdsson I, Sigurdardottir E, Wahlberg A, Zarea I, Aktas T, Andersson I, Hanson Pihlainen E, Ljungman M, Ringman M, Tecleab T, Wehlin L, Allais F, Assuied A, Chêne G, Gilbert C, Jean D, Le Marec F, Moinot L, Reboud P, Rousseau E, Roy C, Schwimmer C, Taïeb L, Wallet C, Derocle G, Gueguen S, Lévy-marchal C, Esperou H, Debrie A, Raze D, Coutte L, Diallo A, Mercier N. Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study. The Lancet Infectious Diseases 2020;20:1290-301. [DOI: 10.1016/s1473-3099(20)30274-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
226 Locht C. Is there a potential for novel, nasal pertussis vaccines? Expert Rev Vaccines 2021;20:415-23. [PMID: 33667341 DOI: 10.1080/14760584.2021.1899823] [Reference Citation Analysis]
227 Gillard J, Blok BA, Garza DR, Venkatasubramanian PB, Simonetti E, Eleveld MJ, Berbers GAM, van Gageldonk PGM, Joosten I, de Groot R, de Bree LCJ, van Crevel R, de Jonge MI, Huynen MA, Netea MG, Diavatopoulos DA. BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trial. NPJ Vaccines 2022;7:21. [PMID: 35177621 DOI: 10.1038/s41541-022-00438-4] [Reference Citation Analysis]
228 Wang P, Huo CX, Lang S, Caution K, Nick ST, Dubey P, Deora R, Huang X. Chemical Synthesis and Immunological Evaluation of a Pentasaccharide Bearing Multiple Rare Sugars as a Potential Anti-pertussis Vaccine. Angew Chem Int Ed Engl 2020;59:6451-8. [PMID: 31953912 DOI: 10.1002/anie.201915913] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
229 Olivera I, Grau C, Dibarboure H, Torres JP, Mieres G, Lazarov L, Alvarez FP, Yescas JGL. Valuing the cost of improving Chilean primary vaccination: a cost minimization analysis of a hexavalent vaccine. BMC Health Serv Res 2020;20:295. [PMID: 32272920 DOI: 10.1186/s12913-020-05115-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
230 MacDougall D, Halperin BA, MacKinnon-Cameron D, Li L, McNeil SA, Langley JM, Halperin SA. Universal tetanus, diphtheria, acellular pertussis (Tdap) vaccination of adults: What Canadian health care providers know and need to know. Hum Vaccin Immunother 2015;11:2167-79. [PMID: 26090861 DOI: 10.1080/21645515.2015.1046662] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
231 Prygiel M, Mosiej E, Wdowiak K, Górska P, Polak M, Lis K, Krysztopa-Grzybowska K, Zasada AA. Effectiveness of experimental and commercial pertussis vaccines in the elimination of Bordetella pertussis isolates with different genetic profiles in murine model. Med Microbiol Immunol 2021. [PMID: 34338880 DOI: 10.1007/s00430-021-00718-1] [Reference Citation Analysis]
232 Debrie A, Mielcarek N, Lecher S, Roux X, Sirard J, Locht C. Early Protection against Pertussis Induced by Live Attenuated Bordetella pertussis BPZE1 Depends on TLR4. J I 2019;203:3293-300. [DOI: 10.4049/jimmunol.1901102] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
233 Nash ZM, Cotter PA. Regulated, sequential processing by multiple proteases is required for proper maturation and release of Bordetella filamentous hemagglutinin. Mol Microbiol 2019;112:820-36. [PMID: 31152610 DOI: 10.1111/mmi.14318] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
234 Healy CM, Rench MA, Wootton SH, Castagnini LA. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatr Infect Dis J 2015;34:22-6. [PMID: 24992123 DOI: 10.1097/INF.0000000000000486] [Cited by in Crossref: 61] [Cited by in F6Publishing: 21] [Article Influence: 8.7] [Reference Citation Analysis]
235 Raeven RH, van der Maas L, Tilstra W, Uittenbogaard JP, Bindels TH, Kuipers B, van der Ark A, Pennings JL, van Riet E, Jiskoot W, Kersten GF, Metz B. Immunoproteomic Profiling of Bordetella pertussis Outer Membrane Vesicle Vaccine Reveals Broad and Balanced Humoral Immunogenicity. J Proteome Res 2015;14:2929-42. [PMID: 25988566 DOI: 10.1021/acs.jproteome.5b00258] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 6.7] [Reference Citation Analysis]
236 Locht C. Pertussis: acellular, whole-cell, new vaccines, what to choose? Expert Rev Vaccines 2016;15:671-3. [PMID: 26938372 DOI: 10.1586/14760584.2016.1161511] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
237 Mitchell TC, Casella CR. No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines. Curr Opin Immunol 2017;47:17-25. [PMID: 28728074 DOI: 10.1016/j.coi.2017.06.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 4.4] [Reference Citation Analysis]
238 de Gouw D, Serra DO, de Jonge MI, Hermans PW, Wessels HJ, Zomer A, Yantorno OM, Diavatopoulos DA, Mooi FR. The vaccine potential of Bordetella pertussis biofilm-derived membrane proteins. Emerg Microbes Infect 2014;3:e58. [PMID: 26038752 DOI: 10.1038/emi.2014.58] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
239 Haut Conseil de la Santé Publique. [Haut Conseil de la santé publique (HCSP). Management of single or multiple pertussis cases]. Rev Mal Respir 2015;32:639-56. [PMID: 26054984 DOI: 10.1016/j.rmr.2014.12.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
240 Asgarian-Omran H, Golara M, Abdolmaleki S, Navabi SS, Alipour H, Khoshnoodi J, Hemmati A, Zarei S, Jeddi-Tehrani M, Shokri F. Restricted antibody response to Bordetella pertussis filamentous hemagglutinin induced by whole-cell and acellular pertussis vaccines. Infect Dis (Lond) 2016;48:127-32. [PMID: 26439274 DOI: 10.3109/23744235.2015.1093655] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
241 Dash N, Verma S. Pertussis and Rotavirus Vaccines - Controversies and Solutions. Indian J Pediatr 2018;85:53-9. [PMID: 28623456 DOI: 10.1007/s12098-017-2393-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
242 Ma L, Caulfield A, Dewan KK, Harvill ET. Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis. Emerg Infect Dis 2021;27:1561-6. [PMID: 34014152 DOI: 10.3201/eid2706.203850] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
243 Cherry JD. The History of Pertussis (Whooping Cough); 1906–2015: Facts, Myths, and Misconceptions. Curr Epidemiol Rep 2015;2:120-30. [DOI: 10.1007/s40471-015-0041-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
244 Fedele G, Cassone A, Ausiello CM. T-cell immune responses to Bordetella pertussis infection and vaccination. Pathog Dis 2015;73:ftv051. [PMID: 26242279 DOI: 10.1093/femspd/ftv051] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
245 Caution K, Yount K, Deora R, Dubey P. Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice. J Vis Exp 2019. [PMID: 30855568 DOI: 10.3791/58930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
246 Snelling TL, Waddington CS. Whither pertussis? Expert Review of Anti-infective Therapy 2014;13:145-8. [DOI: 10.1586/14787210.2015.986462] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
247 Bento AI, King AA, Rohani P. Maternal pertussis immunisation: clinical gains and epidemiological legacy. Euro Surveill 2017;22:30510. [PMID: 28449735 DOI: 10.2807/1560-7917.ES.2017.22.15.30510] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
248 Cherry JD. Editorial Commentary: Tetanus-Diphtheria-Pertussis Immunization in Pregnant Women and the Prevention of Pertussis in Young Infants. Clinical Infectious Diseases 2015;60:338-40. [DOI: 10.1093/cid/ciu823] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
249 Locht C. Live pertussis vaccines: will they protect against carriage and spread of pertussis? Clin Microbiol Infect 2016;22 Suppl 5:S96-S102. [PMID: 28341014 DOI: 10.1016/j.cmi.2016.05.029] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
250 Wang X, Gray MC, Hewlett EL, Maynard JA. The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies. J Biol Chem 2015;290:3576-91. [PMID: 25505186 DOI: 10.1074/jbc.M114.585281] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
251 van den Biggelaar AH, Poolman JT. Predicting future trends in the burden of pertussis in the 21st century: implications for infant pertussis and the success of maternal immunization. Expert Rev Vaccines 2016;15:69-80. [PMID: 26559122 DOI: 10.1586/14760584.2016.1105136] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
252 Hiramatsu Y, Suzuki K, Nishida T, Onoda N, Satoh T, Akira S, Ikawa M, Ikeda H, Kamei J, Derouiche S, Tominaga M, Horiguchi Y. The Mechanism of Pertussis Cough Revealed by the Mouse-Coughing Model. mBio 2022;:e0319721. [PMID: 35357202 DOI: 10.1128/mbio.03197-21] [Reference Citation Analysis]
253 Villarino Romero R, Hasan S, Faé K, Holubova J, Geurtsen J, Schwarzer M, Wiertsema S, Osicka R, Poolman J, Sebo P. Bordetella pertussis filamentous hemagglutinin itself does not trigger anti-inflammatory interleukin-10 production by human dendritic cells. Int J Med Microbiol 2016;306:38-47. [PMID: 26699834 DOI: 10.1016/j.ijmm.2015.11.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
254 Holubová J, Staněk O, Brázdilová L, Mašín J, Bumba L, Gorringe AR, Alexander F, Šebo P. Acellular Pertussis Vaccine Inhibits Bordetella pertussis Clearance from the Nasal Mucosa of Mice. Vaccines (Basel) 2020;8:E695. [PMID: 33228165 DOI: 10.3390/vaccines8040695] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
255 Mertsola J. Editorial commentary: pertussis is less severe in vaccinated than in unvaccinated patients. Clin Infect Dis 2014;58:1530-2. [PMID: 24633682 DOI: 10.1093/cid/ciu161] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
256 Fadugba OO, Wang L, Chen Q, Halasa NB. Immune responses to pertussis antigens in infants and toddlers after immunization with multicomponent acellular pertussis vaccine. Clin Vaccine Immunol 2014;21:1613-9. [PMID: 25253666 DOI: 10.1128/CVI.00438-14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
257 Cattelan N, Jennings-Gee J, Dubey P, Yantorno OM, Deora R. Hyperbiofilm Formation by Bordetella pertussis Strains Correlates with Enhanced Virulence Traits. Infect Immun 2017;85:e00373-17. [PMID: 28893915 DOI: 10.1128/IAI.00373-17] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
258 Jõgi P, Oona M, Kaart T, Toompere K, Maskina T, Koort I, Rätsep A, Lutsar I. Pertussis and parapertussis in children and adults with a persistent cough: an observational study. Infection 2018;46:83-91. [PMID: 29094317 DOI: 10.1007/s15010-017-1095-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
259 Petridou E, Jensen CB, Arvanitidis A, Giannaki-Psinaki M, Michos A, Krogfelt KA, Petersen RF. Molecular epidemiology of Bordetella pertussis in Greece, 2010-2015. J Med Microbiol 2018;67:400-7. [PMID: 29458550 DOI: 10.1099/jmm.0.000688] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
260 Gu XX, Plotkin SA, Edwards KM, Sette A, Mills KHG, Levy O, Sant AJ, Mo A, Alexander W, Lu KT, Taylor CE. Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases. Clin Vaccine Immunol 2017;24:e00034-17. [PMID: 28490424 DOI: 10.1128/CVI.00034-17] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
261 Chow SK, Arbefeville S, Boyanton BL Jr, Dault EM, Dunn J, Ferrieri P, Greene W, Pence MA, Otiso J, Richter S, Schutzbank TE. Multicenter Performance Evaluation of the Simplexa Bordetella Direct Kit in Nasopharyngeal Swab Specimens. J Clin Microbiol 2020;59:e01041-20. [PMID: 33055187 DOI: 10.1128/JCM.01041-20] [Reference Citation Analysis]
262 Pesco P, Bergero P, Fabricius G, Hozbor D. Modelling the effect of changes in vaccine effectiveness and transmission contact rates on pertussis epidemiology. Epidemics 2014;7:13-21. [PMID: 24928665 DOI: 10.1016/j.epidem.2014.04.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
263 Aloe C, Kulldorff M, Bloom BR. Geospatial analysis of nonmedical vaccine exemptions and pertussis outbreaks in the United States. Proc Natl Acad Sci U S A 2017;114:7101-5. [PMID: 28634290 DOI: 10.1073/pnas.1700240114] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
264 Arenas J, Pupo E, Phielix C, David D, Zariri A, Zamyatina A, Tommassen J, van der Ley P. Shortening the Lipid A Acyl Chains of Bordetella pertussis Enables Depletion of Lipopolysaccharide Endotoxic Activity. Vaccines (Basel) 2020;8:E594. [PMID: 33050234 DOI: 10.3390/vaccines8040594] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
265 Campbell PT, McCaw JM, McIntyre P, McVernon J. Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies. Vaccine 2015;33:5794-800. [PMID: 26392008 DOI: 10.1016/j.vaccine.2015.09.025] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
266 Lin A, Apostolovic D, Jahnmatz M, Liang F, Ols S, Tecleab T, Wu C, van Hage M, Solovay K, Rubin K, Locht C, Thorstensson R, Thalen M, Loré K. Live attenuated pertussis vaccine BPZE1 induces a broad antibody response in humans. J Clin Invest 2020;130:2332-46. [PMID: 31945015 DOI: 10.1172/JCI135020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 18.0] [Reference Citation Analysis]
267 van der Lee S, Kemmeren JM, de Rond LGH, Öztürk K, Westerhof A, de Melker HE, Sanders EAM, Berbers GAM, van der Maas NAT, Rümke HC, Buisman AM. Elevated Immune Response Among Children 4 Years of Age With Pronounced Local Adverse Events After the Fifth Diphtheria, Tetanus, Acellular Pertussis Vaccination. Pediatr Infect Dis J 2017;36:e223-9. [PMID: 28430750 DOI: 10.1097/INF.0000000000001620] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
268 Gambhir M, Clark TA, Cauchemez S, Tartof SY, Swerdlow DL, Ferguson NM. A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput Biol 2015;11:e1004138. [PMID: 25906150 DOI: 10.1371/journal.pcbi.1004138] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 9.6] [Reference Citation Analysis]
269 Borba RC, Vidal VM, Moreira LO. The re-emergency and persistence of vaccine preventable diseases. An Acad Bras Cienc 2015;87:1311-22. [PMID: 26312431 DOI: 10.1590/0001-3765201520140663] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
270 Fiasca F, Necozione S, Mattei A. Pertussis in Italy: how to protect the "unprotectable"? Hum Vaccin Immunother 2021;17:1136-41. [PMID: 33121322 DOI: 10.1080/21645515.2020.1806673] [Reference Citation Analysis]
271 Goldsmith JA, DiVenere AM, Maynard JA, McLellan JS. Structural basis for antibody binding to adenylate cyclase toxin reveals RTX linkers as neutralization-sensitive epitopes. PLoS Pathog 2021;17:e1009920. [PMID: 34547035 DOI: 10.1371/journal.ppat.1009920] [Reference Citation Analysis]
272 Bento AI, Riolo MA, Choi YH, King AA, Rohani P. Core pertussis transmission groups in England and Wales: A tale of two eras. Vaccine 2018;36:1160-6. [PMID: 29395520 DOI: 10.1016/j.vaccine.2018.01.046] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
273 Anis E, Moerman L, Ginsberg G, Karakis I, Slater PE, Warshavsky B, Gosinov R, Grotto I, Marva E. Did two booster doses for schoolchildren change the epidemiology of pertussis in Israel? J Public Health Policy 2018;39:304-17. [PMID: 29807998 DOI: 10.1057/s41271-018-0130-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
274 de Jonge EF, van Boxtel R, Balhuizen MD, Haagsman HP, Tommassen J. Pal depletion results in hypervesiculation and affects cell morphology and outer-membrane lipid asymmetry in bordetellae. Research in Microbiology 2022. [DOI: 10.1016/j.resmic.2022.103937] [Reference Citation Analysis]
275 Surendran N, Pichichero M. Genetically detoxified pertussis toxin induces superior antigen specific CD4 T cell responses compared to chemically detoxified pertussis toxin. Hum Vaccin Immunother 2019;15:1167-70. [PMID: 30689515 DOI: 10.1080/21645515.2019.1565270] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
276 Worby CJ, Kenyon C, Lynfield R, Lipsitch M, Goldstein E. Examining the role of different age groups, and of vaccination during the 2012 Minnesota pertussis outbreak. Sci Rep 2015;5:13182. [PMID: 26278132 DOI: 10.1038/srep13182] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
277 Sette A, Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 2021;184:861-80. [PMID: 33497610 DOI: 10.1016/j.cell.2021.01.007] [Cited by in Crossref: 172] [Cited by in F6Publishing: 178] [Article Influence: 172.0] [Reference Citation Analysis]
278 Gasperini G, Biagini M, Arato V, Gianfaldoni C, Vadi A, Norais N, Bensi G, Delany I, Pizza M, Aricò B, Leuzzi R. Outer Membrane Vesicles (OMV)-based and Proteomics-driven Antigen Selection Identifies Novel Factors Contributing to Bordetella pertussis Adhesion to Epithelial Cells. Mol Cell Proteomics 2018;17:205-15. [PMID: 29203497 DOI: 10.1074/mcp.RA117.000045] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
279 Di Mattia G, Nicolai A, Frassanito A, Petrarca L, Nenna R, Midulla F. Pertussis: New preventive strategies for an old disease. Paediatr Respir Rev 2019;29:68-73. [PMID: 29914744 DOI: 10.1016/j.prrv.2018.03.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
280 Ashok Y, Miettinen M, Oliveira DKH, Tamirat MZ, Näreoja K, Tiwari A, Hottiger MO, Johnson MS, Lehtiö L, Pulliainen AT. Discovery of Compounds Inhibiting the ADP-Ribosyltransferase Activity of Pertussis Toxin. ACS Infect Dis 2020;6:588-602. [PMID: 31899865 DOI: 10.1021/acsinfecdis.9b00412] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
281 Mosley YC, Lu F, HogenEsch H. Differences in innate IFNγ and IL-17 responses to Bordetella pertussis between BALB/c and C57BL/6 mice: role of γδT cells, NK cells, and dendritic cells. Immunol Res 2017;65:1139-49. [PMID: 29052125 DOI: 10.1007/s12026-017-8957-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
282 Smallridge WE, Rolin OY, Jacobs NT, Harvill ET. Different effects of whole-cell and acellular vaccines on Bordetella transmission. J Infect Dis 2014;209:1981-8. [PMID: 24443545 DOI: 10.1093/infdis/jiu030] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
283 Patterson J, Kagina BM, Gold M, Hussey GD, Muloiwa R. Adverse events following primary and secondary immunisation with whole-cell pertussis: a systematic review protocol. BMJ Open 2017;7:e012945. [PMID: 28122832 DOI: 10.1136/bmjopen-2016-012945] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
284 Radke S, Petousis-harris H, Watson D, Gentles D, Turner N. Age-specific effectiveness following each dose of acellular pertussis vaccine among infants and children in New Zealand. Vaccine 2017;35:177-83. [DOI: 10.1016/j.vaccine.2016.11.004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
285 Campbell H, Gupta S, Dolan GP, Kapadia SJ, Kumar Singh A, Andrews N, Amirthalingam G. Review of vaccination in pregnancy to prevent pertussis in early infancy. J Med Microbiol 2018;67:1426-56. [PMID: 30222536 DOI: 10.1099/jmm.0.000829] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 11.3] [Reference Citation Analysis]
286 Allen AC, Mills KH. Improved pertussis vaccines based on adjuvants that induce cell-mediated immunity. Expert Rev Vaccines 2014;13:1253-64. [PMID: 25017925 DOI: 10.1586/14760584.2014.936391] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
287 Chasaide CN, Mills KHG. Next-Generation Pertussis Vaccines Based on the Induction of Protective T Cells in the Respiratory Tract. Vaccines (Basel) 2020;8:E621. [PMID: 33096737 DOI: 10.3390/vaccines8040621] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
288 Agricola E, Gesualdo F, Alimenti L, Pandolfi E, Carloni E, D'Ambrosio A, Russo L, Campagna I, Ferretti B, Tozzi AE. Knowledge attitude and practice toward pertussis vaccination during pregnancy among pregnant and postpartum Italian women. Hum Vaccin Immunother 2016;12:1982-8. [PMID: 27712242 DOI: 10.1080/21645515.2016.1188242] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
289 Brousseau N, Skowronski DM, Bellemare D, Amini R, Joffres Y, Clarke Q, Quach C, Rallu F, Hoang L, De Serres G. Impact of the adolescent pertussis booster dose on the incidence of pertussis in British Columbia and Quebec, Canada. Vaccine 2020;38:427-32. [PMID: 31685295 DOI: 10.1016/j.vaccine.2019.10.063] [Reference Citation Analysis]
290 Scheller EV, Melvin JA, Sheets AJ, Cotter PA. Cooperative roles for fimbria and filamentous hemagglutinin in Bordetella adherence and immune modulation. mBio 2015;6:e00500-15. [PMID: 26015497 DOI: 10.1128/mBio.00500-15] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
291 Suzuki K, Shinzawa N, Ishigaki K, Nakamura K, Abe H, Fukui-Miyazaki A, Ikuta K, Horiguchi Y. Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection. Microbiol Immunol 2017;61:371-9. [PMID: 28752940 DOI: 10.1111/1348-0421.12504] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
292 Acosta AM, DeBolt C, Tasslimi A, Lewis M, Stewart LK, Misegades LK, Messonnier NE, Clark TA, Martin SW, Patel M. Tdap vaccine effectiveness in adolescents during the 2012 Washington State pertussis epidemic. Pediatrics 2015;135:981-9. [PMID: 25941309 DOI: 10.1542/peds.2014-3358] [Cited by in Crossref: 73] [Cited by in F6Publishing: 66] [Article Influence: 10.4] [Reference Citation Analysis]
293 Decker MD, Edwards KM. Pertussis (Whooping Cough). J Infect Dis 2021;224:S310-20. [PMID: 34590129 DOI: 10.1093/infdis/jiaa469] [Reference Citation Analysis]
294 Brummelman J, Wilk MM, Han WG, van Els CA, Mills KH. Roads to the development of improved pertussis vaccines paved by immunology. Pathog Dis 2015;73:ftv067. [PMID: 26347400 DOI: 10.1093/femspd/ftv067] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
295 Banerjee A, Bhattacharya P, Joshi AB, Ismail N, Dey R, Nakhasi HL. Role of pro-inflammatory cytokine IL-17 in Leishmania pathogenesis and in protective immunity by Leishmania vaccines. Cell Immunol 2016;309:37-41. [PMID: 27444130 DOI: 10.1016/j.cellimm.2016.07.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 6.2] [Reference Citation Analysis]
296 Rice TF, Diavatopoulos DA, Guo Y, Donaldson B, Bouqueau M, Bosanquet A, Barnett S, Holder B, Kampmann B. Modification of innate immune responses to Bordetella pertussis in babies from pertussis vaccinated pregnancies. EBioMedicine 2021;72:103612. [PMID: 34649076 DOI: 10.1016/j.ebiom.2021.103612] [Reference Citation Analysis]
297 Bone MA, Wilk AJ, Perault AI, Marlatt SA, Scheller EV, Anthouard R, Chen Q, Stibitz S, Cotter PA, Julio SM. Bordetella PlrSR regulatory system controls BvgAS activity and virulence in the lower respiratory tract. Proc Natl Acad Sci U S A 2017;114:E1519-27. [PMID: 28167784 DOI: 10.1073/pnas.1609565114] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
298 Deng N, Ramirez JC, Carey M, Miao H, Arias CA, Rice AP, Wu H. Investigation of temporal and spatial heterogeneities of the immune responses to Bordetella pertussis infection in the lung and spleen of mice via analysis and modeling of dynamic microarray gene expression data. Infect Dis Model 2019;4:215-26. [PMID: 31236525 DOI: 10.1016/j.idm.2019.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
299 Soumana IH, Linz B, Dewan KK, Sarr D, Gestal MC, Howard LK, Caulfield AD, Rada B, Harvill ET. Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice. Emerg Infect Dis 2021;27:2107-16. [PMID: 34286682 DOI: 10.3201/eid2708.203566] [Reference Citation Analysis]
300 Raeven RHM, Rockx-Brouwer D, Kanojia G, van der Maas L, Bindels THE, Ten Have R, van Riet E, Metz B, Kersten GFA. Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses. Sci Rep 2020;10:7396. [PMID: 32355188 DOI: 10.1038/s41598-020-63998-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
301 Meng Q, Li L, Shi W, Wang Q, Ding M, Liu Y, Ma X, Yao K. Seroprevalence of diphtheria and pertussis immunoglobulin G among children with pneumonia in Ji'nan, China. BMC Pediatr 2018;18:383. [PMID: 30518371 DOI: 10.1186/s12887-018-1337-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
302 Heininger U, André P, Chlibek R, Kristufkova Z, Kutsar K, Mangarov A, Mészner Z, Nitsch-Osuch A, Petrović V, Prymula R, Usonis V, Zavadska D. Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013. PLoS One 2016;11:e0155949. [PMID: 27257822 DOI: 10.1371/journal.pone.0155949] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
303 Allen AC, Wilk MM, Misiak A, Borkner L, Murphy D, Mills KHG. Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting TRM cells. Mucosal Immunol 2018;11:1763-76. [PMID: 30127384 DOI: 10.1038/s41385-018-0080-x] [Cited by in Crossref: 45] [Cited by in F6Publishing: 44] [Article Influence: 11.3] [Reference Citation Analysis]
304 Barnett TC, Lim JY, Soderholm AT, Rivera-Hernandez T, West NP, Walker MJ. Host-pathogen interaction during bacterial vaccination. Curr Opin Immunol 2015;36:1-7. [PMID: 25966310 DOI: 10.1016/j.coi.2015.04.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
305 Markey K, Asokanathan C, Feavers I. Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines. Toxins (Basel) 2019;11:E417. [PMID: 31319496 DOI: 10.3390/toxins11070417] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
306 da Silva Antunes R, Babor M, Carpenter C, Khalil N, Cortese M, Mentzer AJ, Seumois G, Petro CD, Purcell LA, Vijayanand P, Crotty S, Pulendran B, Peters B, Sette A. Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters. J Clin Invest 2018;128:3853-65. [PMID: 29920186 DOI: 10.1172/JCI121309] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 12.8] [Reference Citation Analysis]
307 Zahn M. Just when you think you know someone: the evolving epidemiologies of measles and pertussis. Current Opinion in Pediatrics 2016;28:101-6. [DOI: 10.1097/mop.0000000000000307] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
308 Dewan KK, Linz B, DeRocco SE, Harvill ET. Acellular Pertussis Vaccine Components: Today and Tomorrow. Vaccines (Basel) 2020;8:E217. [PMID: 32414005 DOI: 10.3390/vaccines8020217] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
309 Magpantay FMG, Domenech DE Cellès M, Rohani P, King AA. Pertussis immunity and epidemiology: mode and duration of vaccine-induced immunity. Parasitology 2016;143:835-49. [PMID: 26337864 DOI: 10.1017/S0031182015000979] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
310 Havers FP, Cho B, Walker JW, Hariri S. Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States. Vaccine 2020;38:380-7. [DOI: 10.1016/j.vaccine.2019.09.104] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
311 Zar HJ, Moore DP, Andronikou S, Argent AC, Avenant T, Cohen C, Green RJ, Itzikowitz G, Jeena P, Masekela R, Nicol MP, Pillay A, Reubenson G, Madhi SA. Diagnosis and management of community-acquired pneumonia in children: South African Thoracic Society guidelines. Afr J Thorac Crit Care Med 2020;26. [PMID: 34471872 DOI: 10.7196/AJTCCM.2020.v26i3.104] [Reference Citation Analysis]
312 Thalen M, Debrie AS, Coutte L, Raze D, Solovay K, Rubin K, Mielcarek N, Locht C. Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1. Vaccines (Basel) 2020;8:E523. [PMID: 32933132 DOI: 10.3390/vaccines8030523] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
313 Lamberti Y, Cafiero JH, Surmann K, Valdez H, Holubova J, Večerek B, Sebo P, Schmidt F, Völker U, Rodriguez ME. Proteome analysis of Bordetella pertussis isolated from human macrophages. Journal of Proteomics 2016;136:55-67. [DOI: 10.1016/j.jprot.2016.02.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
314 Klein NP, Zerbo O. Use of acellular pertussis vaccines in the United States: can we do better? Expert Rev Vaccines 2017;16:1175-9. [PMID: 29041826 DOI: 10.1080/14760584.2017.1393334] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
315 Urwyler P, Heininger U. Protecting newborns from pertussis - the challenge of complete cocooning. BMC Infect Dis 2014;14:397. [PMID: 25037057 DOI: 10.1186/1471-2334-14-397] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
316 Warfel JM, Papin JF, Wolf RF, Zimmerman LI, Merkel TJ. Maternal and neonatal vaccination protects newborn baboons from pertussis infection. J Infect Dis 2014;210:604-10. [PMID: 24526741 DOI: 10.1093/infdis/jiu090] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
317 Merkel TJ. Toward a Controlled Human Infection Model of Pertussis. Clin Infect Dis 2020;71:412-4. [PMID: 31552410 DOI: 10.1093/cid/ciz842] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
318 Dubois V, Chatagnon J, Thiriard A, Bauderlique-Le Roy H, Debrie AS, Coutte L, Locht C. Suppression of mucosal Th17 memory responses by acellular pertussis vaccines enhances nasal Bordetella pertussis carriage. NPJ Vaccines 2021;6:6. [PMID: 33420041 DOI: 10.1038/s41541-020-00270-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
319 Korppi M. Pertussis - an old disease, new challenges. Acta Paediatr 2014;103:794-5. [PMID: 24802676 DOI: 10.1111/apa.12660] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
320 Siegel SJ, Weiser JN. Mechanisms of Bacterial Colonization of the Respiratory Tract. Annu Rev Microbiol 2015;69:425-44. [PMID: 26488280 DOI: 10.1146/annurev-micro-091014-104209] [Cited by in Crossref: 93] [Cited by in F6Publishing: 84] [Article Influence: 15.5] [Reference Citation Analysis]
321 Cherry JD, Paddock CD. Pathogenesis and histopathology of pertussis: implications for immunization. Expert Rev Vaccines 2014;13:1115-23. [PMID: 24992986 DOI: 10.1586/14760584.2014.935766] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
322 Wolf MA, Boehm DT, DeJong MA, Wong TY, Sen-Kilic E, Hall JM, Blackwood CB, Weaver KL, Kelly CO, Kisamore CA, Bitzer GJ, Bevere JR, Barbier M, Damron FH. Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice. Infect Immun 2021;89:e00607-20. [PMID: 33318136 DOI: 10.1128/IAI.00607-20] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
323 da Silva Antunes R, Quiambao LG, Sutherland A, Soldevila F, Dhanda SK, Armstrong SK, Brickman TJ, Merkel T, Peters B, Sette A. Development and Validation of a Bordetella pertussis Whole-Genome Screening Strategy. J Immunol Res 2020;2020:8202067. [PMID: 32322598 DOI: 10.1155/2020/8202067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
324 Auderset F, Ballester M, Mastelic-Gavillet B, Fontannaz P, Chabaud-Riou M, Reveneau N, Garinot M, Mistretta N, Liu Y, Lambert PH, Ochs M, Siegrist CA. Reactivating Immunity Primed by Acellular Pertussis Vaccines in the Absence of Circulating Antibodies: Enhanced Bacterial Control by TLR9 Rather Than TLR4 Agonist-Including Formulation. Front Immunol 2019;10:1520. [PMID: 31333656 DOI: 10.3389/fimmu.2019.01520] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
325 Goldstein E, Pitzer VE, O'Hagan JJ, Lipsitch M. Temporally Varying Relative Risks for Infectious Diseases: Implications for Infectious Disease Control. Epidemiology 2017;28:136-44. [PMID: 27748685 DOI: 10.1097/EDE.0000000000000571] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
326 Trainor EA, Nicholson TL, Merkel TJ. Bordetella pertussis transmission. Pathog Dis 2015;73:ftv068. [PMID: 26374235 DOI: 10.1093/femspd/ftv068] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
327 Wensley A, Hughes GJ, Campbell H, Amirthalingam G, Andrews N, Young N, Coole L. Risk factors for pertussis in adults and teenagers in England. Epidemiol Infect 2017;145:1025-36. [DOI: 10.1017/s0950268816002983] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
328 Gregg KA, Merkel TJ. Pertussis Toxin: A Key Component in Pertussis Vaccines? Toxins (Basel) 2019;11:E557. [PMID: 31546599 DOI: 10.3390/toxins11100557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
329 Brennan MJ. A New Whooping Cough Vaccine That May Prevent Colonization and Transmission. Vaccines (Basel) 2017;5:E43. [PMID: 29125532 DOI: 10.3390/vaccines5040043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
330 Scanlon KM, Gau Y, Zhu J, Skerry C, Wall SM, Soleimani M, Carbonetti NH. Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection. Infect Immun 2014;82:4212-21. [PMID: 25069981 DOI: 10.1128/IAI.02222-14] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
331 Luu LDW, Octavia S, Zhong L, Raftery MJ, Sintchenko V, Lan R. Comparison of the Whole Cell Proteome and Secretome of Epidemic Bordetella pertussis Strains From the 2008-2012 Australian Epidemic Under Sulfate-Modulating Conditions. Front Microbiol 2018;9:2851. [PMID: 30538686 DOI: 10.3389/fmicb.2018.02851] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
332 Nokhodian Z, Ataei B, Zahraei SM, Gouya MM, Hoseini SG, Yaran M, Mansourian M, Motlagh ME, Heshmat R, Kelishadi R. Seroprevalence of Bordetella pertussis among a nationally representative sample of Iranian pediatric population: The childhood and adolescence surveillance and prevention of adult noncommunicable disease-V study. J Res Med Sci 2021;26:21. [PMID: 34267793 DOI: 10.4103/jrms.JRMS_636_19] [Reference Citation Analysis]
333 Mahmud AS, Lipsitch M, Goldstein E. On the role of different age groups during pertussis epidemics in California, 2010 and 2014. Epidemiol Infect 2019;147:e184. [PMID: 31063110 DOI: 10.1017/S0950268819000761] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
334 Voysey M, Kandasamy R, Yu L, Baudin M, Sadorge C, Thomas S, John T, Pollard AJ. The predicted persistence and kinetics of antibody decline 9 years after pre-school booster vaccination in UK children. Vaccine 2016;34:4221-8. [DOI: 10.1016/j.vaccine.2016.06.051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
335 Scheller EV, Cotter PA. Bordetella filamentous hemagglutinin and fimbriae: critical adhesins with unrealized vaccine potential. Pathog Dis 2015;73:ftv079. [PMID: 26416077 DOI: 10.1093/femspd/ftv079] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
336 Esposito S. Prevention of pertussis: from clinical trials to Real World Evidence. J Prev Med Hyg 2018;59:E177-86. [PMID: 30397673 DOI: 10.15167/2421-4248/jpmh2018.59.3.1041] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
337 Paradowska-Stankiewicz I, Rumik A, Bogusz J, Zbrzeźniak J, Rastawicki W, Śmietańska K, Vargas-Zambrano JC, Macina D. Duration of protection against Bordetella pertussis infection elicited by whole-cell and acellular vaccine priming in Polish children and adolescents. Vaccine 2021;39:6067-73. [PMID: 34511302 DOI: 10.1016/j.vaccine.2021.08.105] [Reference Citation Analysis]
338 Li P, Asokanathan C, Liu F, Khaing KK, Kmiec D, Wei X, Song B, Xing D, Kong D. PLGA nano/micro particles encapsulated with pertussis toxoid (PTd) enhances Th1/Th17 immune response in a murine model. Int J Pharm 2016;513:183-90. [PMID: 27586408 DOI: 10.1016/j.ijpharm.2016.08.059] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
339 Zanaboni E, Arato V, Pizza M, Seubert A, Leuzzi R. A novel high-throughput assay to quantify the vaccine-induced inhibition of Bordetella pertussis adhesion to airway epithelia. BMC Microbiol 2016;16:215. [PMID: 27633511 DOI: 10.1186/s12866-016-0829-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
340 Miller LA, Royer CM, Pinkerton KE, Schelegle ES. Nonhuman Primate Models of Respiratory Disease: Past, Present, and Future. ILAR J 2017;58:269-80. [PMID: 29216343 DOI: 10.1093/ilar/ilx030] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
341 Saul N, Wang K, Bag S, Baldwin H, Alexander K, Chandra M, Thomas J, Quinn H, Sheppeard V, Conaty S. Effectiveness of maternal pertussis vaccination in preventing infection and disease in infants: The NSW Public Health Network case-control study. Vaccine 2018;36:1887-92. [PMID: 29501321 DOI: 10.1016/j.vaccine.2018.02.047] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 10.0] [Reference Citation Analysis]
342 Zerbo O, Fireman B, Klein NP. Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness. Expert Rev Vaccines 2021;:1-9. [PMID: 34555994 DOI: 10.1080/14760584.2021.1984891] [Reference Citation Analysis]
343 Locht C, Papin JF, Lecher S, Debrie AS, Thalen M, Solovay K, Rubin K, Mielcarek N. Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection. J Infect Dis 2017;216:117-24. [PMID: 28535276 DOI: 10.1093/infdis/jix254] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
344 Godoy P, García-Cenoz M, Toledo D, Carmona G, Caylà JA, Alsedà M, Àlvarez J, Barrabeig I, Camps N, Plans P, Company M, Castilla J, Sala-Farré MR, Muñoz-Almagro C, Rius C, Domínguez À; Transmission of Pertussis in Households Working Group. Factors influencing the spread of pertussis in households: a prospective study, Catalonia and Navarre, Spain, 2012 to 2013. Euro Surveill 2016;21:30393. [PMID: 27918260 DOI: 10.2807/1560-7917.ES.2016.21.45.30393] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
345 Kiraly N, Koplin JJ, Crawford NW, Bannister S, Flanagan KL, Holt PG, Gurrin LC, Lowe AJ, Tang MLK, Wake M, Ponsonby A, Dharmage SC, Allen KJ. Timing of routine infant vaccinations and risk of food allergy and eczema at one year of age. Allergy 2016;71:541-9. [DOI: 10.1111/all.12830] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]